Results for Projects
Project: Asian/Pacific Islander Community Exposures (ACE) Project - ACE 1
- Study Group: 100 Chinese adults living in the San Francisco Bay area
- Sample Collection Date:
Chemical Group: Metals
- Measured in: Blood
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| Cadmium | Cadmium | NA | µg/L | 96 | 0.524 | 0.462 | 0.595 | 0.344 | 0.520 | 0.801 | 1.15 | 99% | 0.150 |
| Lead | Lead | NA | µg/dL | 96 | 1.23 | 1.11 | 1.37 | 0.843 | 1.23 | 1.90 | 2.37 | 100% | 0.0500 |
| Mercury | Mercury | NA | µg/L | 96 | 3.58 | 3.01 | 4.26 | 2.47 | 4.12 | 7.13 | 9.24 | 100% | 0.150 |
Chemical Group: Metals
- Measured in: Urine
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Arsenic | Arsenic | NA | µg/L | 100 | 22.2 | 18.2 | 27.0 | 12.6 | 22.1 | 44.0 | 131 | 100% | 0.162 |
| Cadmium | Cadmium | Creatinine | µg/g creatinine | 100 | 0.450 | 0.377 | 0.536 | 0.222 | 0.460 | 0.913 | 1.75 | 97% | 0.0391 µg/L |
| Mercury | Mercury | NA | µg/L | 100 | 0.301 | 0.246 | 0.367 | 0.135 | 0.301 | 0.599 | 1.71 | 99% | 0.0300 |
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| 4:2 FTS | 4:2 FTS | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 5:3 FTCA | 5:3 FTCA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 6:2 diPAP | 6:2 diPAP | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 7.3% | 0.0500 |
| 6:2 FTCA | 6:2 FTCA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 |
| 6:2 FTS | 6:2 FTS | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 6:2 FTUCA | 6:2 FTUCA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 6:6 PFPiA | 6:6 PFPiA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 6:8 PFPiA | 6:8 PFPiA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 7:3 FTCA | 7:3 FTCA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 8:2 diPAP | 8:2 diPAP | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 |
| 8:2 FTCA | 8:2 FTCA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.500 |
| 8:2 FTS | 8:2 FTS | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 8:2 FTUCA | 8:2 FTUCA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 8:2 PAP | 8:2 PAP | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.500 |
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.2% | 0.0500 |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/ml | 96 | 0.0523 | 0.0421 | 0.0650 | 0.0256 | 0.0467 | 0.0959 | 0.228 | 95.8% | 0.0120 |
| PFBA | PFBA | NA | ng/ml | 96 | * | * | * | <LOD | 0.0582 | 0.0846 | 0.140 | 62.5% | 0.0500 |
| PFBS | PFBS | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0442 |
| PFDA | PFDA | NA | ng/ml | 96 | 0.477 | 0.406 | 0.559 | 0.281 | 0.453 | 0.739 | 1.49 | 80.2% | 0.250 |
| PFDoA | PFDoA | NA | ng/ml | 96 | * | * | * | <LOD | 0.0540 | 0.0788 | 0.134 | 56.3% | 0.0500 |
| PFDS | PFDS | NA | ng/ml | 96 | * | * | * | <LOD | 0.0104 | 0.0204 | 0.048 | 53.1% | 0.00965 |
| PFHpA | PFHpA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | 0.0574 | 0.0868 | 30.2% | 0.0500 |
| PFHxA | PFHxA | NA | ng/ml | 96 | 0.176 | 0.162 | 0.191 | 0.151 | 0.180 | 0.214 | 0.276 | 97.9% | 0.0556 |
| PFHxPA | PFHxPA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| PFHxS | PFHxS | NA | ng/ml | 96 | 0.767 | 0.66 | 0.891 | 0.432 | 0.789 | 1.41 | 1.81 | 100% | 0.00945 |
| PFNA | PFNA | NA | ng/ml | 96 | 0.987 | 0.870 | 1.12 | 0.65 | 0.948 | 1.33 | 2.24 | 99% | 0.250 |
| PFOA | PFOA | NA | ng/ml | 96 | 1.41 | 1.23 | 1.61 | 0.998 | 1.36 | 2.16 | 2.85 | 100% | 0.0500 |
| PFOPA | PFOPA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| PFOS | PFOS | NA | ng/ml | 96 | 6.51 | 5.49 | 7.73 | 3.32 | 6.05 | 11.7 | 19.3 | 100% | 0.0566 |
| PFOSA | PFOSA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| PFPeA | PFPeA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| PFUnDA | PFUnDA | NA | ng/ml | 96 | 0.398 | 0.348 | 0.455 | 0.301 | 0.427 | 0.600 | 0.824 | 100% | 0.0500 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Project: Asian/Pacific Islander Community Exposures (ACE) Project - ACE 2
- Study Group: 100 Vietnamese adults living in the San Francisco Bay area
- Sample Collection Date:
Chemical Group: Metals
- Measured in: Blood
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| Cadmium | Cadmium | NA | µg/L | 99 | 0.592 | 0.526 | 0.666 | 0.374 | 0.609 | 0.892 | 1.29 | 100% | 0.0750 |
| Lead | Lead | NA | µg/dL | 99 | 1.12 | 1.02 | 1.22 | 0.858 | 1.06 | 1.41 | 2.07 | 100% | 0.0250 |
| Mercury | Mercury | NA | µg/L | 99 | 4.77 | 4.13 | 5.51 | 3.22 | 5.18 | 8.04 | 9.99 | 100% | 0.0750 |
Chemical Group: Metals
- Measured in: Urine
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Arsenic | Arsenic | NA | µg/L | 100 | 33.6 | 27.4 | 41.1 | 18.0 | 35.4 | 70.5 | 121 | 100% | 0.100 |
| Cadmium | Cadmium | Creatinine | µg/g | 100 | 0.625 | 0.527 | 0.740 | 0.353 | 0.712 | 1.12 | 2.16 | 99% | 0.0300 µg/L |
| Mercury | Mercury | NA | µg/L | 100 | 0.432 | 0.349 | 0.535 | 0.218 | 0.418 | 0.816 | 2.11 | 97% | 0.0500 |
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| 4:2 FTS | 4:2 FTS | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 5:3 FTCA | 5:3 FTCA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2% | 0.0500 |
| 6:2 diPAP | 6:2 diPAP | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2% | 0.0500 |
| 6:2 FTCA | 6:2 FTCA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 |
| 6:2 FTS | 6:2 FTS | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3% | 0.0500 |
| 6:2 FTUCA | 6:2 FTUCA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 6:6 PFPiA | 6:6 PFPiA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0100 |
| 6:8 PFPiA | 6:8 PFPiA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 7:3 FTCA | 7:3 FTCA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.1% | 0.0500 |
| 8:2 diPAP | 8:2 diPAP | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 |
| 8:2 FTCA | 8:2 FTCA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.500 |
| 8:2 FTS | 8:2 FTS | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 8:2 FTUCA | 8:2 FTUCA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 8:2 PAP | 8:2 PAP | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.500 |
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3% | 0.0500 |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/ml | 99 | 0.0342 | 0.0291 | 0.0402 | 0.0197 | 0.0282 | 0.0538 | 0.114 | 97% | 0.0120 |
| PFBA | PFBA | NA | ng/ml | 99 | 0.0589 | 0.0531 | 0.0655 | <LOD | 0.0580 | 0.0736 | 0.0996 | 67.7% | 0.0500 |
| PFBS | PFBS | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3% | 0.0400 |
| PFDA | PFDA | NA | ng/ml | 99 | 0.559 | 0.490 | 0.636 | 0.393 | 0.541 | 0.823 | 1.28 | 87.9% | 0.250 |
| PFDoA | PFDoA | NA | ng/ml | 99 | * | * | * | <LOD | 0.0135 | 0.0226 | 0.0441 | 52.5% | 0.0500 |
| PFDS | PFDS | NA | ng/ml | 99 | * | * | * | <LOD | 0.0505 | 0.0773 | 0.127 | 59.6% | 0.0100 |
| PFHpA | PFHpA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | 0.0699 | 20.2% | 0.0500 |
| PFHxA | PFHxA | NA | ng/ml | 99 | 0.189 | 0.166 | 0.215 | 0.124 | 0.174 | 0.268 | 0.453 | 98% | 0.0600 |
| PFHxPA | PFHxPA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| PFHxS | PFHxS | NA | ng/ml | 99 | 1.29 | 1.14 | 1.45 | 0.787 | 1.21 | 1.81 | 3.05 | 100% | 0.0100 |
| PFNA | PFNA | NA | ng/ml | 99 | 1.10 | 0.988 | 1.22 | 0.84 | 1.08 | 1.49 | 2.21 | 99% | 0.250 |
| PFOA | PFOA | NA | ng/ml | 99 | 1.69 | 1.51 | 1.88 | 1.20 | 1.61 | 2.30 | 3.06 | 100% | 0.0600 |
| PFOPA | PFOPA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| PFOS | PFOS | NA | ng/ml | 99 | 7.47 | 6.38 | 8.75 | 4.17 | 7.00 | 11.5 | 22.9 | 100% | 0.191 |
| PFOSA | PFOSA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3% | 0.0100 |
| PFPeA | PFPeA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| PFUnDA | PFUnDA | NA | ng/ml | 99 | 0.453 | 0.391 | 0.525 | 0.309 | 0.443 | 0.740 | 1.12 | 98% | 0.0500 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Chemical Group: Environmental Phenols
- Measured in: Urine
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Benzophenone-3 | Benzophenone-3 | NA | µg/L | 109 | 24.4 | 16.0 | 37.2 | 5.70 | 22.8 | 86.7 | 797 | 94.5% | 0.500 µg/L |
| BPA | Bisphenol A | NA | µg/L | 109 | 1.40 | 1.08 | 1.80 | 0.660 | 1.31 | 2.82 | 13.3 | 89.9% | 0.200 µg/L |
| Butyl paraben | Butyl Paraben | NA | µg/L | 109 | * | * | * | <LOD | <LOD | <LOD | 13.5 | 21.1% | 0.500 µg/L |
| Ethyl paraben | Ethyl Paraben | NA | µg/L | 109 | * | * | * | <LOD | <LOD | 6.83 | 127 | 44.0% | 0.500 µg/L |
| Methyl paraben | Methyl Paraben | NA | µg/L | 105 | 78.4 | 56.2 | 109 | 21.7 | 76.4 | 282 | 1,060 | 99.0% | 0.500 µg/L |
| Propyl paraben | Propyl Paraben | NA | µg/L | 109 | 7.66 | 4.89 | 12.0 | 0.555 | 8.38 | 49.1 | 367 | 75.2% | 0.500 µg/L |
| Triclosan | Triclosan | NA | µg/L | 109 | 11.7 | 7.77 | 17.5 | 2.54 | 9.29 | 44.3 | 702 | 96.3% | 0.200 µg/L |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Herbicides
- Measured in: Urine
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| 2,4-D | 2_4-D | NA | µg/L | 109 | 0.304 | 0.245 | 0.376 | 0.163 | 0.340 | 0.617 | 1.92 | 90.8% | 0.0500 µg/L |
Chemical Group: Metals
- Measured in: Blood
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Cadmium | Cadmium | NA | µg/L | 110 | 0.271 | 0.237 | 0.311 | 0.170 | 0.275 | 0.390 | 0.990 | 100% | 0.06 µg/L |
| Lead | Lead | NA | µg/dL | 110 | 1.05 | 0.931 | 1.18 | 0.700 | 1.05 | 1.47 | 2.45 | 100% | 0.02 µg/dL |
| Manganese | Manganese | NA | µg/L | 110 | 8.09 | 7.62 | 8.58 | 6.50 | 8.40 | 9.80 | 13.4 | 100% | 0.45 µg/L |
| Mercury | Mercury | NA | µg/L | 110 | 0.748 | 0.602 | 0.929 | 0.370 | 0.745 | 1.79 | 4.26 | 99.1% | 0.04 µg/L |
Chemical Group: Metals
- Measured in: Urine
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Arsenic | Arsenic | NA | µg/L | 108 | 11.6 | 9.30 | 14.5 | 5.08 | 10.9 | 21.5 | 102 | 100% | 0.0493 µg/L |
| Cadmium | Cadmium | Creatinine | µg/g creatinine | 108 | 0.301 | 0.267 | 0.339 | 0.186 | 0.300 | 0.461 | 0.853 | 100% | 0.0420 µg/L |
| Mercury | Mercury | NA | µg/L | 108 | 0.210 | 0.168 | 0.263 | 0.087 | 0.217 | 0.509 | 1.14 | 98.1% | 0.0163 µg/L |
Chemical Group: Pesticidas Organoclorados
- Measured in: Serum
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | Lipids | ng/g lipid | 110 | 7.00 | 5.42 | 9.05 | 2.98 | 5.94 | 11.5 | 115 | 89.1% | 0.00800 ng/mL |
| DDE (para,para) | para,para-DDT and/or para,para-DDE | Lipids | ng/g lipid | 110 | 321 | 266 | 386 | 161 | 318 | 585 | 2180 | 100.0% | 0.0160 ng/mL |
| DDT (ortho,para) | ortho,para-DDT | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.0% | 0.00800 ng/mL |
| DDT (para,para) | para,para-DDT | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | 10.6 | 15.5% | 0.00800 ng/mL |
| Hexachlorobenzene (HCB) | HCB | Lipids | ng/g lipid | 110 | 11.6 | 10.8 | 12.5 | 9.21 | 11.4 | 14.0 | 20.6 | 100.0% | 0.00800 ng/mL |
| Oxychlordane | Chlordane | Lipids | ng/g lipid | 110 | 7.61 | 6.41 | 9.02 | 5.45 | 8.30 | 13.2 | 28.4 | 91.8% | 0.00800 ng/mL |
| trans-Nonachlor | Chlordane | Lipids | ng/g lipid | 110 | 14.3 | 12.0 | 17.0 | 8.31 | 14.5 | 25.1 | 60.8 | 99.1% | 0.00800 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Pesticidas Organofosfatos
- Measured in: Urine
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| IMPY | Diazinon | NA | µg/L | 109 | * | * | * | <LOD | <LOD | 0.0944 | 0.708 | 35.8% | 0.0500 µg/L |
| TCPy | Chlorpyrifos, Chlorpyrifos-methyl | NA | µg/L | 109 | 1.23 | 1.05 | 1.45 | 0.706 | 1.24 | 2.24 | 4.40 | 80.7% | 0.500 µg/L |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Other Pesticides
- Measured in: Urine
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| DEET | DEET | NA | µg/L | 109 | * | * | * | <LOD | <LOD | <LOD | 0.502 | 12.8% | 0.0500 µg/L |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Perchlorate
- Measured in: Urine
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Perchlorate | NA | µg/L | 102 | 3.77 | 3.23 | 4.39 | 2.26 | 3.76 | 5.95 | 13.9 | 100% | 0.500 µg/L | |
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 110 | * | * | * | <LOD | <LOD | 0.022 | 0.163 | 24.5% | 0.0313 ng/mL |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 110 | 0.174 | 0.142 | 0.213 | 0.0945 | 0.165 | 0.329 | 1.350 | 95.5% | 0.0277 ng/mL |
| PFBS | PFBS | NA | ng/mL | 110 | * | * | * | <LOD | <LOD | <LOD | 0.0680 | 11.8% | 0.0411 ng/mL |
| PFDA | PFDA | NA | ng/mL | 110 | 0.245 | 0.216 | 0.278 | 0.160 | 0.254 | 0.334 | 0.767 | 100% | 0.0349 ng/mL |
| PFDoA | PFDoA | NA | ng/mL | 110 | 0.0191 | 0.0166 | 0.0221 | <LOD | 0.0193 | 0.0303 | 0.0595 | 70.0% | 0.0114 ng/mL |
| PFHpA | PFHpA | NA | ng/mL | 110 | 0.0483 | 0.0395 | 0.0591 | 0.0246 | 0.0543 | 0.0901 | 0.269 | 87.3% | 0.010 ng/mL |
| PFHxS | PFHxS | NA | ng/mL | 110 | 1.43 | 1.19 | 1.73 | 0.917 | 1.52 | 2.43 | 6.87 | 99.1% | 0.0206 ng/mL |
| PFNA | PFNA | NA | ng/mL | 110 | 0.994 | 0.920 | 1.07 | 0.730 | 0.984 | 1.35 | 1.86 | 100% | 0.0154 ng/mL |
| PFOA | PFOA | NA | ng/mL | 110 | 1.97 | 1.76 | 2.19 | 1.36 | 1.99 | 2.92 | 4.70 | 100% | 0.0087 ng/mL |
| PFOS | PFOS | NA | ng/mL | 110 | 7.00 | 6.12 | 8.00 | 4.66 | 7.10 | 10.4 | 25.8 | 100% | 0.0621 ng/mL |
| PFOSA | PFOSA | NA | ng/mL | 110 | * | * | * | <LOD | 0.0254 | 0.0487 | 0.195 | 52.7% | 0.0225 ng/mL |
| PFUnDA | PFUnDA | NA | ng/mL | 110 | 0.128 | 0.111 | 0.148 | 0.0737 | 0.123 | 0.195 | 0.533 | 100% | 0.0254 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Ftalatos
- Measured in: Urine
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| MBzP | Benzylbutyl phthalate (BzBP) | NA | µg/L | 109 | 7.49 | 5.99 | 9.36 | 3.65 | 7.27 | 18.6 | 41.9 | 100% | 0.250 µg/L |
| MCHP | Dicyclohexyl phthalate (DCHP) | NA | µg/L | 109 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.83% | 0.500 µg/L |
| MCPP | Di-n-octyl phthalate (DnOP) | NA | µg/L | 109 | 1.88 | 1.52 | 2.32 | 1.03 | 1.64 | 3.41 | 14.6 | 100% | 0.125 µg/L |
| MECPP | Di-2-ethylhexyl phthalate (DEHP) | NA | µg/L | 109 | 12.1 | 10.0 | 14.7 | 7.10 | 11.7 | 20.0 | 51.7 | 100% | 0.500 µg/L |
| MEP | Diethyl phthalate (DEP) | NA | µg/L | 109 | 57.1 | 45.2 | 72.1 | 25.5 | 52.1 | 103 | 584 | 97.2% | 8.00 µg/L |
| MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | NA | µg/L | 109 | 19.0 | 16.1 | 22.4 | 11.7 | 18.5 | 31.6 | 73.5 | 98.2% | 2.00 µg/L |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: éteres Difenílicos Polibromados (PBDEs)
- Measured in: Serum
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| BDE 017 | BDE 17 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.8% | 0.003 ng/mL |
| BDE 028 | BDE 28 | Lipids | ng/g lipid | 110 | 1.81 | 1.52 | 2.16 | 1.02 | 1.64 | 2.63 | 10.2 | 91.8% | 0.003 ng/mL |
| BDE 047 | BDE 47 | Lipids | ng/g lipid | 110 | 25.8 | 21.0 | 31.6 | 12.3 | 26.9 | 43.2 | 134 | 99.1% | 0.023 ng/mL |
| BDE 066 | BDE 66 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | 1.02 | 9.1% | 0.004 ng/mL |
| BDE 085 | BDE 85 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | 3.49 | 20.0% | 0.004 ng/mL |
| BDE 099 | BDE 99 | Lipids | ng/g lipid | 110 | 4.75 | 3.85 | 5.85 | 2.08 | 4.30 | 8.36 | 54.7 | 80.9% | 0.012 ng/mL |
| BDE 100 | BDE 100 | Lipids | ng/g lipid | 110 | 4.02 | 3.24 | 4.98 | 2.07 | 3.72 | 6.75 | 39.1 | 89.1% | 0.006 ng/mL |
| BDE 153 | BDE 153 | Lipids | ng/g lipid | 110 | 13.9 | 11.6 | 16.8 | 7.08 | 12.5 | 24.6 | 98.4 | 99.1% | 0.008 ng/mL |
| BDE 154 | BDE 154 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | 5.12 | 17.3% | 0.007 ng/mL |
| BDE 183 | BDE 183 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.6% | 0.007 ng/mL |
| BDE 196 | BDE 196 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.7% | 0.010 ng/mL |
| BDE 197 | BDE 197 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | 1.76 | 4.38 | 42.7% | 0.007 ng/mL |
| BDE 201 | BDE 201 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.5% | 0.006 ng/mL |
| BDE 202 | BDE 202 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.9% | 0.007 ng/mL |
| BDE 203 | BDE 203 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.9% | 0.007 ng/mL |
| BDE 206 | BDE 206 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.5% | 0.009 ng/mL |
| BDE 207 | BDE 207 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | 2.57 | 18.2% | 0.011 ng/mL |
| BDE 208 | BDE 208 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.7% | 0.010 ng/mL |
| BDE 209 | BDE 209 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | 5.65 | 15.5 | 38.2% | 0.030 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Bifenilos Policlorados (PCBs)
- Measured in: Serum
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| PCB 066 | PCB 066 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | 1.45 | 2.84 | 38.2% | 0.00800 ng/mL |
| PCB 074 | PCB 074 | Lipids | ng/g lipid | 110 | 3.63 | 3.12 | 4.23 | 1.91 | 3.27 | 7.18 | 13.1 | 92.7% | 0.00800 ng/mL |
| PCB 099 | PCB 099 | Lipids | ng/g lipid | 110 | 2.89 | 2.49 | 3.36 | 1.61 | 2.81 | 4.31 | 11.9 | 85.5% | 0.00800 ng/mL |
| PCB 101 | PCB 101 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | 1.36 | 2.34 | 28.2% | 0.00800 ng/mL |
| PCB 105 | PCB 105 | Lipids | ng/g lipid | 110 | * | * | * | <LOD | <LOD | 1.73 | 4.54 | 41.8% | 0.00800 ng/mL |
| PCB 118 | PCB 118 | Lipids | ng/g lipid | 110 | 4.84 | 4.10 | 5.71 | 2.43 | 4.14 | 8.48 | 19.8 | 96.4% | 0.00800 ng/mL |
| PCB 138 | PCB 138 | Lipids | ng/g lipid | 110 | 9.60 | 8.11 | 11.4 | 5.18 | 9.81 | 16.7 | 43.4 | 98.2% | 0.00800 ng/mL |
| PCB 153 | PCB 153 | Lipids | ng/g lipid | 110 | 22.0 | 18.5 | 26.1 | 12.8 | 24.7 | 40.5 | 99.0 | 99.1% | 0.00800 ng/mL |
| PCB 156 | PCB 156 | Lipids | ng/g lipid | 110 | 3.48 | 2.99 | 4.06 | 1.85 | 3.66 | 5.69 | 13.7 | 85.5% | 0.00800 ng/mL |
| PCB 170 | PCB 170 | Lipids | ng/g lipid | 110 | 6.30 | 5.36 | 7.40 | 3.99 | 6.85 | 11.9 | 23.2 | 92.7% | 0.00800 ng/mL |
| PCB 180 | PCB 180 | Lipids | ng/g lipid | 110 | 21.8 | 18.2 | 26.2 | 13.8 | 25.7 | 41.9 | 79.6 | 99.1% | 0.00800 ng/mL |
| PCB 183 | PCB 183 | Lipids | ng/g lipid | 110 | 2.00 | 1.75 | 2.29 | <LOD | 1.90 | 3.26 | 8.51 | 66.4% | 0.00800 ng/mL |
| PCB 187 | PCB 187 | Lipids | ng/g lipid | 110 | 6.38 | 5.37 | 7.58 | 3.60 | 6.90 | 11.7 | 25.0 | 91.8% | 0.00800 ng/mL |
| PCB 194 | PCB 194 | Lipids | ng/g lipid | 110 | 5.24 | 4.45 | 6.17 | 2.96 | 5.50 | 9.87 | 19.2 | 89.1% | 0.00800 ng/mL |
| PCB 203 | PCB 203 | Lipids | ng/g lipid | 110 | 3.15 | 2.71 | 3.66 | 1.55 | 3.41 | 5.35 | 10.8 | 81.8% | 0.00800 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Hidrocarburos Aromáticos Policíclicos (PAHs)
- Measured in: Urine
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| 1-NAP | Naphthalene | NA | pg/mL | 109 | 1,650 | 1,260 | 2,150 | 668 | 1,430 | 3,630 | 18,100 | 100.0% | 25 pg/mL |
| 1-PHEN | Phenanthrene | NA | pg/mL | 109 | 126 | 106 | 149 | 80.2 | 133 | 259 | 478 | 99.1% | 10 pg/mL |
| 1-PYR | Pyrene | NA | pg/mL | 109 | 93.0 | 75.1 | 115 | 49.3 | 88.1 | 177 | 665 | 88.1% | 20 pg/mL |
| 2-FLUO | Fluorene | NA | pg/mL | 109 | 246 | 198 | 305 | 121 | 232 | 387 | 2,290 | 100.0% | 20 pg/mL |
| 2-NAP | Naphthalene | NA | pg/mL | 109 | 4,290 | 3,450 | 5,340 | 1,950 | 4,190 | 10,200 | 25,000 | 100.0% | 20 pg/mL |
| 2-PHEN | Phenanthrene | NA | pg/mL | 109 | 39.1 | 33.6 | 45.5 | 24.4 | 41.8 | 70.3 | 119 | 93.6% | 10 pg/mL |
| 3-FLUO | Fluorene | NA | pg/mL | 109 | 124 | 97.9 | 157 | 54.2 | 103 | 227 | 1,580 | 95.4% | 20 pg/mL |
| 3-PHEN | Phenanthrene | NA | pg/mL | 109 | 57.4 | 47.8 | 68.9 | 31.7 | 53.1 | 117 | 285 | 96.3% | 10 pg/mL |
| 9-FLUO | Fluorene | NA | pg/mL | 109 | 323 | 268 | 389 | 184 | 312 | 607 | 1,940 | 99.1% | 37 pg/mL |
Chemical Group: Pesticidas Piretroides
- Measured in: Urine
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| 3-Phenoxybenzoic acid (3-PBA) | Cyhalothrin, cypermethrin, deltamethrin, fenpropathrin, permethrin, and/or tralomethrin | NA | µg/L | 109 | 0.774 | 0.609 | 0.983 | 0.390 | 0.736 | 1.79 | 5.95 | 98.2% | 0.0500 µg/L |
| 4-Fluoro-3-phenoxybenzoic acid (4F-3-PBA) | Cyfluthrin | NA | µg/L | 109 | * | * | * | <LOD | <LOD | <LOD | 0.143 | 14.7% | 0.0500 µg/L |
| Trans-DCCA | Cyfluthrin, cypermethrin, permethrin | NA | µg/L | 109 | 0.614 | 0.476 | 0.792 | 0.258 | 0.555 | 1.21 | 7.42 | 98.2% | 0.0500 µg/L |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Chemical Group: Environmental Phenols
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Benzophenone-3 | Benzophenone-3 | NA | µg/L | 218 | 76.7 | 43.4 | 135 | 10.9 | 76.2 | 431 | 6720 | 95.8% | 1.00 µg/L | ● |
| Benzophenone-3 | Benzophenone-3 | Creatinine | µg/g creatinine | 218 | 83.8 | 49.1 | 143 | 11.8 | 70.8 | 408 | 3520 | 95.8% | 1.00 µg/L | ● |
| BPA | Bisphenol A | NA | µg/L | 218 | 1.33 | 1.05 | 1.69 | 0.648 | 1.52 | 3.56 | 5.66 | 97.4% | 0.100 µg/L | ● |
| BPA | Bisphenol A | Creatinine | µg/g creatinine | 218 | 1.46 | 1.20 | 1.77 | 0.786 | 1.53 | 2.39 | 5.58 | 97.4% | 0.100 µg/L | ● |
| Butyl paraben | Butyl paraben | NA | µg/L | 218 | * | * | * | <LOD | <LOD | 0.456 | 20.5 | 33.4% | 0.200 µg/L | ● |
| Butyl paraben | Butyl paraben | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | 0.834 | 21.2 | 33.4% | 0.200 µg/L | ● |
| Ethyl paraben | Ethyl paraben | NA | µg/L | 218 | * | * | * | <LOD | <LOD | 10.0 | 168 | 47.8% | 1.00 µg/L | ● |
| Ethyl paraben | Ethyl paraben | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | 11.7 | 161 | 47.8% | 1.00 µg/L | ● |
| Methyl paraben | Methyl paraben | NA | µg/L | 218 | 62.9 | 41.3 | 95.9 | 21.1 | 75.4 | 241 | 906 | 94.3% | 1.00 µg/L | ● |
| Methyl paraben | Methyl paraben | Creatinine | µg/g creatinine | 218 | 68.8 | 47.6 | 99.6 | 23.5 | 83.8 | 237 | 924 | 94.3% | 1.00 µg/L | ● |
| Propyl paraben | Propyl paraben | NA | µg/L | 218 | 9.58 | 5.98 | 15.4 | <LOD | 9.05 | 55.5 | 325 | 71.5% | 1.00 µg/L | ● |
| Propyl paraben | Propyl paraben | Creatinine | µg/g creatinine | 218 | 10.48 | 6.68 | 16.4 | <LOD | 9.51 | 70.2 | 287 | 71.5% | 1.00 µg/L | ● |
| Triclosan | Triclosan | NA | µg/L | 218 | 11.9 | 7.34 | 19.4 | 2.25 | 9.09 | 60.4 | 801 | 98.5% | 0.100 µg/L | ● |
| Triclosan | Triclosan | Creatinine | µg/g creatinine | 218 | 13.1 | 8.00 | 21.3 | 2.31 | 11.3 | 54.2 | 812 | 98.5% | 0.100 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Herbicides
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| 2,4-D | 2,4-D | NA | µg/L | 218 | 0.173 | 0.137 | 0.217 | 0.0807 | 0.159 | 0.302 | 1.29 | 81.9% | 0.0500 µg/L | ● |
| 2,4-D | 2,4-D | Creatinine | µg/g creatinine | 218 | 0.189 | 0.153 | 0.233 | 0.113 | 0.185 | 0.323 | 1.61 | 81.9% | 0.0500 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
Chemical Group: Metals
- Measured in: Blood
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Cadmium | Cadmium | NA | µg/L | 315 | 0.247 | 0.220 | 0.277 | 0.161 | 0.227 | 0.380 | 0.939 | 100% | 0.0111 µg/L | □ |
| Lead | Lead | NA | µg/dL | 315 | 0.749 | 0.664 | 0.846 | 0.416 | 0.703 | 1.31 | 2.43 | 100% | 0.0109 µg/dL | □ |
| Manganese | Manganese | NA | µg/L | 315 | 9.17 | 8.76 | 9.60 | 7.63 | 9.08 | 10.8 | 15.7 | 100% | 1.00 µg/L | □ |
| Mercury | Mercury | NA | µg/L | 315 | 0.677 | 0.573 | 0.799 | 0.339 | 0.693 | 1.26 | 3.52 | 99.9% | 0.0294 µg/L | □ |
Footnotes
- □Expanded BEST data from 315 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
Chemical Group: Metals
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Arsenic | Arsenic | NA | µg/L | 218 | 8.60 | 7.05 | 10.5 | 5.08 | 10.3 | 14.0 | 41.6 | 100% | 0.0493 µg/L | ● |
| Arsenic | Arsenic | Creatinine | µg/g creatinine | 218 | 9.40 | 8.25 | 10.71 | 5.35 | 9.29 | 13.8 | 29 | 100% | 0.0493 µg/L | ● |
| Cadmium | Cadmium | NA | µg/L | 218 | 0.184 | 0.145 | 0.235 | 0.0932 | 0.173 | 0.412 | 1.02 | 87.8% | 0.0420 µg/L | ● |
| Cadmium | Cadmium | Creatinine | µg/g creatinine | 218 | 0.202 | 0.166 | 0.245 | 0.111 | 0.193 | 0.334 | 0.928 | 87.8% | 0.0420 µg/L | ● |
| Cobalt | Cobalt | NA | µg/L | 218 | 0.190 | 0.146 | 0.247 | 0.0872 | 0.181 | 0.417 | 1.24 | 98.5% | 0.0113 µg/L | ● |
| Cobalt | Cobalt | Creatinine | µg/g creatinine | 218 | 0.207 | 0.168 | 0.256 | 0.113 | 0.166 | 0.305 | 1.36 | 98.5% | 0.0113 µg/L | ● |
| Manganese | Manganese | NA | µg/L | 218 | * | * | * | <LOD | 0.0555 | 0.106 | 0.461 | 56.3% | 0.0449 µg/L | ● |
| Manganese | Manganese | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | 0.0632 | 0.123 | 0.89 | 56.3% | 0.0449 µg/L | ● |
| Mercury | Mercury | NA | µg/L | 218 | 0.148 | 0.114 | 0.194 | 0.0766 | 0.154 | 0.358 | 1.09 | 93.9% | 0.0163 µg/L | ● |
| Mercury | Mercury | Creatinine | µg/g creatinine | 218 | 0.162 | 0.130 | 0.202 | 0.0756 | 0.182 | 0.314 | 0.811 | 93.9% | 0.0163 µg/L | ● |
| Molybdenum | Molybdenum | NA | µg/L | 218 | 40.4 | 31.8 | 51.4 | 20.0 | 48.6 | 81.1 | 202 | 100% | 0.0736 µg/L | ● |
| Molybdenum | Molybdenum | Creatinine | µg/g creatinine | 218 | 44.2 | 36.9 | 52.9 | 28.8 | 40.2 | 71.0 | 158 | 100% | 0.0736 µg/L | ● |
| Thallium | Thallium | NA | µg/L | 218 | 0.164 | 0.136 | 0.197 | 0.125 | 0.182 | 0.296 | 0.373 | 98.4% | 0.00982 µg/L | ● |
| Thallium | Thallium | Creatinine | µg/g creatinine | 218 | 0.179 | 0.161 | 0.198 | 0.135 | 0.180 | 0.247 | 0.392 | 98.4% | 0.00982 µg/L | ● |
| Tungsten | Tungsten | NA | µg/L | 218 | 0.0762 | 0.0584 | 0.0994 | 0.0447 | 0.0924 | 0.155 | 0.333 | 95.8% | 0.00493 µg/L | ● |
| Tungsten | Tungsten | Creatinine | µg/g creatinine | 218 | 0.0833 | 0.0684 | 0.101 | 0.0475 | 0.0812 | 0.141 | 0.399 | 95.8% | 0.00493 µg/L | ● |
| Uranium | Uranium | NA | µg/L | 218 | 0.00709 | 0.00533 | 0.00944 | 0.00215 | 0.00752 | 0.0181 | 0.0635 | 82.0% | 0.00134 µg/L | ● |
| Uranium | Uranium | Creatinine | µg/g creatinine | 218 | 0.00775 | 0.00606 | 0.00990 | 0.00349 | 0.00664 | 0.0149 | 0.0645 | 82.0% | 0.00134 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Pesticidas Organoclorados
- Measured in: Serum
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | 5.22 | 24.7 | 35.5% | 0.00800 ng/mL | ♦ |
| DDE (para,para) | para,para-DDT and/or para,para-DDE | Lipids | ng/g lipid | 217 | 217 | 176 | 267 | 110 | 174 | 542 | 1240 | 100% | 0.0160 ng/mL | ♦ |
| DDT (ortho,para) | ortho,para-DDT | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.5% | 0.00800 ng/mL | ♦ |
| DDT (para,para) | para,para-DDT | Lipids | ng/g lipid | 217 | * | * | * | <LOD | 1.71 | 2.58 | 4.98 | 64.2% | 0.00800 ng/mL | ♦ |
| Hexachlorobenzene (HCB) | HCB | Lipids | ng/g lipid | 217 | 8.82 | 8.21 | 9.47 | 7.27 | 8.71 | 11.1 | 16.1 | 100% | 0.0106 ng/mL | ♦ |
| Oxychlordane | Chlordane | Lipids | ng/g lipid | 217 | 3.73 | 3.09 | 4.50 | 2.00 | 3.54 | 7.37 | 15.0 | 83.4% | 0.00800 ng/mL | ♦ |
| trans-Nonachlor | Chlordane | Lipids | ng/g lipid | 217 | 6.92 | 5.68 | 8.44 | 3.69 | 6.43 | 14.9 | 34.4 | 89.9% | 0.00800 ng/mL | ♦ |
Footnotes
- ♦Expanded BEST data from 217 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Pesticidas Organofosfatos
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| IMPY | Diazanon | NA | µg/L | 218 | * | * | * | <LOD | <LOD | 0.199 | 0.849 | 47.5% | 0.0500 µg/L | ● |
| IMPY | Diazanon | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | 0.216 | 0.829 | 47.5% | 0.0500 µg/L | ● |
| TCPy | Chlorpyrifos (Chlorpyrifos methyl) | NA | µg/L | 218 | 0.912 | 0.792 | 1.05 | <LOD | 0.991 | 1.39 | 2.72 | 74.6% | 0.500 µg/L | ● |
| TCPy | Chlorpyrifos (Chlorpyrifos methyl) | Creatinine | µg/g creatinine | 218 | 0.997 | 0.883 | 1.13 | <LOD | 0.953 | 1.40 | 2.61 | 74.6% | 0.500 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Other Pesticides
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| DEET | DEET | NA | µg/L | 218 | * | * | * | <LOD | <LOD | 0.102 | 0.286 | 38.5% | 0.0500 µg/L | ● |
| DEET | DEET | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | 0.117 | 0.425 | 38.5% | 0.0500 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Perchlorate
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Perchlorate | NA | µg/L | 218 | 2.91 | 2.38 | 3.56 | 2.00 | 2.98 | 4.59 | 18.6 | 100% | 0.0100 µg/L | ● | |
| Perchlorate | Creatinine | µg/g creatinine | 218 | 3.19 | 2.68 | 3.79 | 1.79 | 2.87 | 5.47 | 13.9 | 100% | 0.0100 µg/L | ● | |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 337 | * | * | * | <LOD | 0.00732 | 0.0218 | 0.0865 | 51.7% | 0.00682 ng/mL | ○ |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 337 | 0.120 | 0.106 | 0.136 | 0.0686 | 0.124 | 0.202 | 0.514 | 98.4% | 0.0114 ng/mL | ○ |
| PFDA | PFDA | NA | ng/mL | 337 | 0.162 | 0.146 | 0.180 | 0.0901 | 0.161 | 0.262 | 0.522 | 79.1% | 0.0877 ng/mL | ○ |
| PFDoA | PFDoA | NA | ng/mL | 337 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.4% | 0.148 ng/mL | ○ |
| PFHpA | PFHpA | NA | ng/mL | 337 | * | * | * | <LOD | 0.0189 | 0.0480 | 0.135 | 61.4% | 0.0121 ng/mL | ○ |
| PFHxS | PFHxS | NA | ng/mL | 337 | 1.09 | 0.952 | 1.26 | 0.606 | 1.13 | 1.85 | 4.59 | 99.5% | 0.0538 ng/mL | ○ |
| PFNA | PFNA | NA | ng/mL | 337 | 0.739 | 0.660 | 0.827 | 0.497 | 0.764 | 1.18 | 1.95 | 99.5% | 0.0282 ng/mL | ○ |
| PFOA | PFOA | NA | ng/mL | 337 | 1.42 | 1.26 | 1.60 | 1.04 | 1.63 | 2.34 | 4.07 | 99.5% | 0.0426 ng/mL | ○ |
| PFOS | PFOS | NA | ng/mL | 337 | 5.07 | 4.53 | 5.68 | 3.41 | 5.05 | 7.82 | 17.6 | 99.7% | 0.0943 ng/mL | ○ |
| PFOSA | PFOSA | NA | ng/mL | 337 | * | * | * | <LOD | <LOD | 0.0246 | 0.108 | 29.2% | 0.0212 ng/mL | ○ |
| PFUnDA | PFUnDA | NA | ng/mL | 337 | 0.0841 | 0.0743 | 0.0952 | 0.0447 | 0.0820 | 0.138 | 0.363 | 80.3% | 0.0371 ng/mL | ○ |
Footnotes
- ○Expanded BEST data from 337 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Ftalatos
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| MBzP | Benzylbutyl phthalate (BzBP) | NA | µg/L | 218 | 5.20 | 4.09 | 6.61 | 2.82 | 5.57 | 9.44 | 25.6 | 100% | 0.200 µg/L | ● |
| MBzP | Benzylbutyl phthalate (BzBP) | Creatinine | µg/g creatinine | 218 | 5.69 | 4.81 | 6.72 | 3.36 | 5.86 | 9.05 | 22.3 | 100% | 0.200 µg/L | ● |
| MCHP | Dicyclohexyl phthalate (DCHP) | NA | µg/L | 218 | * | * | * | <LOD | <LOD | <LOD | <LOD | <0.1% | 0.100 µg/L | ● |
| MCHP | Dicyclohexyl phthalate (DCHP) | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | <LOD | <LOD | <0.1% | 0.100 µg/L | ● |
| MCPP | Di-n-octyl phthalate (DnOP) | NA | µg/L | 218 | 2.01 | 1.57 | 2.58 | 0.943 | 2.30 | 4.40 | 16.0 | >99.9% | 0.100 µg/L | ● |
| MCPP | Di-n-octyl phthalate (DnOP) | Creatinine | µg/g creatinine | 218 | 2.20 | 1.79 | 2.71 | 1.17 | 1.87 | 3.54 | 15.2 | >99.9% | 0.100 µg/L | ● |
| MECPP | Di-2-ethylhexyl phthalate (DEHP) | NA | µg/L | 218 | 9.62 | 7.62 | 12.1 | 5.35 | 11.0 | 20.5 | 47.9 | 100% | 0.190 µg/L | ● |
| MECPP | Di-2-ethylhexyl phthalate (DEHP) | Creatinine | µg/g creatinine | 218 | 10.52 | 9.01 | 12.3 | 6.81 | 10.5 | 16.9 | 36.1 | 100% | 0.190 µg/L | ● |
| MEHHP | Di-2-ethylhexyl phthalate (DEHP) | NA | µg/L | 218 | 6.05 | 4.67 | 7.83 | 2.70 | 7.17 | 12.7 | 31.9 | >99.9% | 0.190 µg/L | ● |
| MEHHP | Di-2-ethylhexyl phthalate (DEHP) | Creatinine | µg/g creatinine | 218 | 6.61 | 5.50 | 7.94 | 4.33 | 6.75 | 10.4 | 19.6 | >99.9% | 0.190 µg/L | ● |
| MEHP | Di-2-ethylhexyl phthalate (DEHP) | NA | µg/L | 218 | 1.89 | 1.38 | 2.59 | 0.857 | 2.28 | 5.21 | 13.3 | 89.9% | 0.190 µg/L | ● |
| MEHP | Di-2-ethylhexyl phthalate (DEHP) | Creatinine | µg/g creatinine | 218 | 2.07 | 1.63 | 2.62 | 0.936 | 2.16 | 4.24 | 12.9 | 89.9% | 0.190 µg/L | ● |
| MEOHP | Di-2-ethylhexyl phthalate (DEHP) | NA | µg/L | 218 | 4.49 | 3.43 | 5.87 | 2.37 | 4.87 | 8.27 | 35.0 | >99.9% | 0.100 µg/L | ● |
| MEOHP | Di-2-ethylhexyl phthalate (DEHP) | Creatinine | µg/g creatinine | 218 | 4.91 | 4.02 | 6.00 | 3.00 | 4.96 | 7.06 | 21.5 | >99.9% | 0.100 µg/L | ● |
| MEP | Diethyl phthalate (DEP) | NA | µg/L | 218 | 52.6 | 38.5 | 72.0 | 20.7 | 43.0 | 118 | 930 | 100% | 0.460 µg/L | ● |
| MEP | Diethyl phthalate (DEP) | Creatinine | µg/g creatinine | 218 | 57.5 | 44.3 | 74.6 | 23.9 | 46.2 | 120 | 534 | 100% | 0.460 µg/L | ● |
| MIBP | Di-isobutyl phthalate (DIBP) | NA | µg/L | 218 | 6.88 | 5.70 | 8.32 | 3.84 | 6.35 | 12.2 | 25.4 | 93.3% | 1.60 µg/L | ● |
| MIBP | Di-isobutyl phthalate (DIBP) | Creatinine | µg/g creatinine | 218 | 7.52 | 6.50 | 8.72 | 4.91 | 7.22 | 11.5 | 27.5 | 93.3% | 1.60 µg/L | ● |
| MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | NA | µg/L | 218 | 13.8 | 11.0 | 17.4 | 7.75 | 15.7 | 25.4 | 69.9 | 96.8% | 0.910 µg/L | ● |
| MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | Creatinine | µg/g creatinine | 218 | 15.1 | 12.9 | 17.7 | 8.67 | 15.4 | 22.5 | 51.8 | 96.8% | 0.910 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: éteres Difenílicos Polibromados (PBDEs)
- Measured in: Serum
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| BDE 017 | BDE 17 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.00770 ng/mL | ♦ * |
| BDE 028 | BDE 28 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | 2.61 | 5.04 | 47.4% | 0.00800 ng/mL | ♦ |
| BDE 047 | BDE 47 | Lipids | ng/g lipid | 217 | 20.8 | 17.2 | 25.2 | 9.64 | 22.0 | 42.8 | 108 | 99.2% | 0.0165 ng/mL | ♦ |
| BDE 066 | BDE 66 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.6% | 0.00800 ng/mL | ♦ |
| BDE 085 | BDE 85 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | 1.94 | 9.7% | 0.00800 ng/mL | ♦ |
| BDE 099 | BDE 99 | Lipids | ng/g lipid | 217 | 4.35 | 3.57 | 5.3 | 2.06 | 3.97 | 9.65 | 22.6 | 88.1% | 0.00898 ng/mL | ♦ |
| BDE 100 | BDE 100 | Lipids | ng/g lipid | 217 | 4.21 | 3.44 | 5.14 | 1.67 | 4.18 | 9.14 | 23.6 | 84.9% | 0.00800 ng/mL | ♦ |
| BDE 153 | BDE 153 | Lipids | ng/g lipid | 217 | 11.3 | 9.29 | 13.7 | 6.43 | 10.0 | 16.8 | 83.0 | 94.6% | 0.0160 ng/mL | ♦ |
| BDE 154 | BDE 154 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.3% | 0.0160 ng/mL | ♦ |
| BDE 183 | BDE 183 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.9% | 0.0160 ng/mL | ♦ |
| BDE 196 | BDE 196 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0160 ng/mL | ♦ |
| BDE 197 | BDE 197 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | 3.53 | 7.4% | 0.0160 ng/mL | ♦ |
| BDE 201 | BDE 201 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0160 ng/mL | ♦ |
| BDE 202 | BDE 202 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0160 ng/mL | ♦ |
| BDE 203 | BDE 203 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0160 ng/mL | ♦ |
| BDE 206 | BDE 206 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.4% | 0.0200 ng/mL | ♦ |
| BDE 207 | BDE 207 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.9% | 0.0200 ng/mL | ♦ |
| BDE 208 | BDE 208 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.4% | 0.0200 ng/mL | ♦ |
| BDE 209 | BDE 209 | Lipids | ng/g lipid | 190 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.4% | 0.257 ng/mL | ♦ |
Footnotes
- ♦Expanded BEST data from 217 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Bifenilos Policlorados (PCBs)
- Measured in: Serum
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| PCB 066 | PCB 066 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | 1.94 | 9.7% | 0.00800 ng/mL | ♦ |
| PCB 074 | PCB 074 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | 4.27 | 11.6 | 47.1% | 0.00800 ng/mL | ♦ |
| PCB 099 | PCB 099 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | 1.61 | 3.10 | 8.05 | 58.0% | 0.00800 ng/mL | ♦ |
| PCB 101 | PCB 101 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.5% | 0.00800 ng/mL | ♦ |
| PCB 105 | PCB 105 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | 3.47 | 18.9% | 0.00800 ng/mL | ♦ |
| PCB 118 | PCB 118 | Lipids | ng/g lipid | 217 | 2.85 | 2.34 | 3.46 | 1.29 | 2.52 | 4.78 | 13.4 | 77.5% | 0.00800 ng/mL | ♦ |
| PCB 138 | PCB 138 | Lipids | ng/g lipid | 217 | 5.11 | 4.08 | 6.39 | 2.32 | 4.32 | 10.6 | 25.6 | 93.1% | 0.00800 ng/mL | ♦ |
| PCB 153 | PCB 153 | Lipids | ng/g lipid | 217 | 10.1 | 7.88 | 12.8 | 4.00 | 9.18 | 26.2 | 56.5 | 99.7% | 0.00800 ng/mL | ♦ |
| PCB 156 | PCB 156 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | 1.53 | 3.45 | 7.94 | 52.6% | 0.00800 ng/mL | ♦ |
| PCB 170 | PCB 170 | Lipids | ng/g lipid | 217 | 3.49 | 2.82 | 4.32 | <LOD | 3.50 | 8.88 | 16.1 | 71.7% | 0.00800 ng/mL | ♦ |
| PCB 180 | PCB 180 | Lipids | ng/g lipid | 217 | 9.42 | 7.26 | 12.2 | 3.07 | 9.40 | 29.3 | 54.0 | 97.7% | 0.00800 ng/mL | ♦ |
| PCB 183 | PCB 183 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | 2.67 | 5.13 | 43.7% | 0.00800 ng/mL | ♦ |
| PCB 187 | PCB 187 | Lipids | ng/g lipid | 217 | 3.14 | 2.55 | 3.88 | <LOD | 2.96 | 8.63 | 16.3 | 69.4% | 0.00800 ng/mL | ♦ |
| PCB 194 | PCB 194 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | 2.08 | 5.33 | 11.9 | 58.8% | 0.00800 ng/mL | ♦ |
| PCB 203 | PCB 203 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | 2.33 | 5.57 | 11.5 | 61.5% | 0.00800 ng/mL | ♦ |
Footnotes
- ♦Expanded BEST data from 217 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Hidrocarburos Aromáticos Policíclicos (PAHs)
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| 1-NAP | Naphthalene | NA | pg/mL | 218 | 1,230 | 873 | 1,730 | 569 | 1,060 | 2,740 | 14,700 | 98.4% | 25 pg/mL | ● |
| 1-NAP | Naphthalene | Creatinine | ng/g creatinine | 218 | 1,340 | 983 | 1,840 | 567 | 948 | 2,530 | 18,100 | 98.4% | 25 pg/mL | ● |
| 1-PHEN | Phenanthrene | NA | pg/mL | 218 | 104 | 84.4 | 129 | 69.9 | 106 | 179 | 521 | 97.9% | 10 pg/mL | ● |
| 1-PHEN | Phenanthrene | Creatinine | ng/g creatinine | 218 | 114 | 95.6 | 136 | 64.4 | 107 | 164 | 427 | 97.9% | 10 pg/mL | ● |
| 1-PYR | Pyrene | NA | pg/mL | 218 | 105 | 83.0 | 134 | 56.8 | 102 | 205 | 497 | 90.5% | 20 pg/mL | ● |
| 1-PYR | Pyrene | Creatinine | ng/g creatinine | 218 | 115 | 93.9 | 141 | 62.6 | 104 | 151 | 909 | 90.5% | 20 pg/mL | ● |
| 2-FLUO | Fluorene | NA | pg/mL | 218 | 201 | 164 | 245 | 118 | 209 | 325 | 922 | 98.4% | 20 pg/mL | ● |
| 2-FLUO | Fluorene | Creatinine | ng/g creatinine | 218 | 219 | 185 | 260 | 127 | 178 | 299 | 1,160 | 98.4% | 20 pg/mL | ● |
| 2-NAP | Naphthalene | NA | pg/mL | 218 | 3,640 | 2,990 | 4,420 | 1,780 | 3,490 | 7,940 | 19,500 | 100% | 20 pg/mL | ● |
| 2-NAP | Naphthalene | Creatinine | ng/g creatinine | 218 | 3,980 | 3,330 | 4,750 | 1,920 | 3,740 | 6,820 | 19,900 | 100% | 20 pg/mL | ● |
| 2-PHEN | Phenanthrene | NA | pg/mL | 218 | 35.0 | 29.0 | 42.1 | 21.1 | 39.0 | 55.7 | 164 | 91.2% | 10 pg/mL | ● |
| 2-PHEN | Phenanthrene | Creatinine | ng/g creatinine | 218 | 38.2 | 32.5 | 44.9 | 24.3 | 34.5 | 54.6 | 134 | 91.2% | 10 pg/mL | ● |
| 3-FLUO | Fluorene | NA | pg/mL | 218 | 96.3 | 74.1 | 125 | 43.9 | 90.4 | 163 | 1150 | 89.8% | 20 pg/mL | ● |
| 3-FLUO | Fluorene | Creatinine | ng/g creatinine | 218 | 105 | 83.4 | 133 | 53.2 | 82.8 | 148 | 1,140 | 89.8% | 20 pg/mL | ● |
| 3-PHEN | Phenanthrene | NA | pg/mL | 218 | 56.1 | 45.5 | 69.3 | 37.2 | 57.3 | 109 | 247 | 93.3% | 10 pg/mL | ● |
| 3-PHEN | Phenanthrene | Creatinine | ng/g creatinine | 218 | 61.4 | 51.3 | 73.4 | 34.5 | 56.2 | 78.3 | 468 | 93.3% | 10 pg/mL | ● |
| 9-FLUO | Fluorene | NA | pg/mL | 218 | 274 | 217 | 344 | 143 | 271 | 507 | 2140 | 96.3% | 37 pg/mL | ● |
| 9-FLUO | Fluorene | Creatinine | ng/g creatinine | 218 | 299 | 246 | 363 | 156 | 266 | 478 | 1,890 | 96.3% | 37 pg/mL | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
Chemical Group: Pesticidas Piretroides
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| 3-Phenoxybenzoic acid (3-PBA) | Cyhalothrin, cypermethrin, deltamethrin, fenpropathrin, permethrin, and/or tralomethrin | NA | µg/L | 218 | 0.660 | 0.480 | 0.908 | 0.305 | 0.783 | 1.47 | 5.39 | 90.9% | 0.0500 µg/L | ● |
| 3-Phenoxybenzoic acid (3-PBA) | Cyhalothrin, cypermethrin, deltamethrin, fenpropathrin, permethrin, and/or tralomethrin | Creatinine | µg/g creatinine | 218 | 0.722 | 0.558 | 0.934 | 0.386 | 0.747 | 1.27 | 6.41 | 90.9% | 0.0500 µg/L | ● |
| 4-Fluoro-3-phenoxybenzoic acid (4F-3-PBA) | Cyfluthrin | NA | µg/L | 218 | * | * | * | <LOD | <LOD | <LOD | 0.224 | 19.7% | 0.0500 µg/L | ● |
| 4-Fluoro-3-phenoxybenzoic acid (4F-3-PBA) | Cyfluthrin | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | <LOD | 0.230 | 19.7% | 0.0500 µg/L | ● |
| Trans-DCCA | Cyfluthrin, cypermethrin, permethrin | Creatinine | µg/g creatinine | 218 | 0.505 | 0.383 | 0.666 | 0.221 | 0.488 | 1.15 | 6.30 | 92.6% | 0.0500 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Project: California Childhood Leukemia Study (CCLS)
- Study Group: 48 Mothers
- Sample Collection Date: -
Chemical Group: Pesticidas Organoclorados
- Measured in: Serum
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | Lipids | ng/g lipid | 48 | 5.7 | 3.8 | 8.5 | <LOD | 5.9 | 10 | 29 | 69% | 0.010 ng/mL |
| DDE (para,para) | DDT (para,para) and/or DDE (para,para) | Lipids | ng/g lipid | 48 | 190 | 160 | 230 | 120 | 180 | 290 | 420 | 100% | 0.027 ng/mL |
| DDT (ortho,para) | DDT (ortho,para) | Lipids | ng/g lipid | 48 | 3.7 | 3.0 | 4.6 | <LOD | 5.3 | 7.1 | 8.2 | 69% | 0.012 ng/mL |
| DDT (para,para) | DDT (para,para) | Lipids | ng/g lipid | 48 | 4.3 | 3.5 | 5.2 | 3.3 | 4.1 | 6.3 | 9.0 | 88% | 0.010 ng/mL |
| Hexachlorobenzene (HCB) | HCB | Lipids | ng/g lipid | 48 | 7.7 | 7.2 | 8.1 | 6.8 | 7.8 | 8.5 | 10 | 100% | 0.010 ng/mL |
| Oxychlordane | Chlordane | Lipids | ng/g lipid | 48 | 4.6 | 4.1 | 5.2 | 3.9 | 5.0 | 5.8 | 7.1 | 98% | 0.010 ng/mL |
| trans-Nonachlor | Chlordane | Lipids | ng/g lipid | 48 | 8.8 | 7.7 | 10 | 6.7 | 8.8 | 11 | 15 | 100% | 0.011 ng/mL |
Chemical Group: éteres Difenílicos Polibromados (PBDEs)
- Measured in: Serum
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| BDE 047 | BDE 47 | Lipids | ng/g lipid | 48 | 43 | 33 | 56 | 23 | 35 | 68 | 110 | 98% | 0.074 ng/mL |
| BDE 099 | BDE 99 | Lipids | ng/g lipid | 48 | 11 | 8.5 | 14 | 6.5 | 10.1 | 12.7 | 25 | 100% | 0.018 ng/mL |
| BDE 100 | BDE 100 | Lipids | ng/g lipid | 48 | 12 | 10 | 15 | 8.0 | 10 | 15 | 22 | 100% | 0.015 ng/mL |
| BDE 153 | BDE 153 | Lipids | ng/g lipid | 48 | 10 | 7.6 | 14 | 5.0 | 8.9 | 16 | 46 | 96% | 0.015 ng/mL |
| BDE 154 | BDE 154 | Lipids | ng/g lipid | 48 | * | * | * | <LOD | <LOD | 3.6 | 5.7 | 48% | 0.015 ng/mL |
Chemical Group: Bifenilos Policlorados (PCBs)
- Measured in: Serum
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| PCB 028 | PCB 28 | Lipids | ng/g lipid | 48 | 4.1 | 3.6 | 4.7 | <LOD | 3.6 | 4.3 | 6.8 | 100% | 0.010 ng/mL |
| PCB 066 | PCB 66 | Lipids | ng/g lipid | 48 | 2.2 | 1.9 | 2.4 | 1.7 | 2.3 | 2.9 | 3.4 | 85% | 0.010 ng/mL |
| PCB 074 | PCB 74 | Lipids | ng/g lipid | 48 | 3.0 | 2.7 | 3.3 | 2.4 | 3.2 | 3.8 | 4.2 | 98% | 0.010 ng/mL |
| PCB 099 | PCB 99 | Lipids | ng/g lipid | 48 | 2.7 | 2.5 | 3.1 | 2.2 | 3.0 | 3.5 | 4.3 | 90% | 0.010 ng/mL |
| PCB 101 | PCB 101 | Lipids | ng/g lipid | 48 | 1.7 | 1.5 | 1.9 | <LOD | 1.8 | 2.3 | 2.9 | 65% | 0.010 ng/mL |
| PCB 105 | PCB 105 | Lipids | ng/g lipid | 48 | 1.9 | 1.7 | 2.1 | <LOD | 2.0 | 2.5 | 2.7 | 73% | 0.010 ng/mL |
| PCB 118 | PCB 118 | Lipids | ng/g lipid | 48 | 4.0 | 3.7 | 4.5 | 3.2 | 4.0 | 5.4 | 6.7 | 100% | 0.010 ng/mL |
| PCB 138 | PCB 138 | Lipids | ng/g lipid | 48 | 6.8 | 5.9 | 7.9 | 4.8 | 6.4 | 9.4 | 14 | 100% | 0.010 ng/mL |
| PCB 153 | PCB 153 | Lipids | ng/g lipid | 48 | 11 | 8.9 | 13 | 6.5 | 9.7 | 17 | 28 | 100% | 0.010 ng/mL |
| PCB 156 | PCB 156 | Lipids | ng/g lipid | 48 | 2.6 | 2.3 | 2.9 | 1.9 | 2.5 | 3.4 | 4.1 | 94% | 0.010 ng/mL |
| PCB 167 | PCB 167 | Lipids | ng/g lipid | 48 | * | * | * | <LOD | 1.6 | 2.1 | 2.3 | 60% | 0.010 ng/mL |
| PCB 170 | PCB 170 | Lipids | ng/g lipid | 48 | 4.6 | 4.0 | 5.3 | 3.2 | 4.4 | 6.6 | 9.9 | 100% | 0.010 ng/mL |
| PCB 180 | PCB 180 | Lipids | ng/g lipid | 48 | 10 | 8.4 | 12 | 6.1 | 9.3 | 15 | 25 | 100% | 0.010 ng/mL |
| PCB 183 | PCB 183 | Lipids | ng/g lipid | 48 | 2.2 | 2.0 | 2.5 | 1.6 | 2.4 | 2.8 | 3.3 | 81% | 0.011 ng/mL |
| PCB 187 | PCB 187 | Lipids | ng/g lipid | 48 | 3.5 | 3.1 | 4.1 | 2.5 | 3.4 | 4.6 | 7.2 | 100% | 0.010 ng/mL |
| PCB 194 | PCB 194 | Lipids | ng/g lipid | 48 | 3.1 | 2.8 | 3.5 | 2.3 | 3.2 | 4.2 | 5.4 | 100% | 0.010 ng/mL |
| PCB 203 | PCB 203 | Lipids | ng/g lipid | 48 | 3.0 | 2.7 | 3.3 | 2.2 | 3.1 | 4.0 | 5.3 | 100% | 0.010 ng/mL |
Project: California Regional Exposure Study, Los Angeles County (CARE-LA)
- Study Group: 430 adults (age 18 and up) living in Los Angeles County
- Sample Collection Date:
Chemical Group: Environmental Phenols
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Benzophenone-3 | Benzophenone-3 | NA | ng/ml | 406 | 26.6 | 19.5 | 36.3 | 7.12 | 21.1 | 89.6 | 783 | 95.8% | 0.500 and 1.000 ng/ml** | ▶ ◘ |
| Benzophenone-3 | Benzophenone-3 | Creatinine | µg/g creatinine | 404 | 35.3 | 24.8 | 50.2 | 8.33 | 26.7 | 113 | 2,010 | 95.8% | 0.500 and 1.000 ng/ml** | ▶ ◘ |
| BPA | Bisphenol A | NA | ng/ml | 406 | 0.444 | 0.353 | 0.558 | 0.148 | 0.405 | 1.26 | 5.09 | 77.5% | 0.100 ng/ml | ▶ ◘ |
| BPA | Bisphenol A | Creatinine | µg/g creatinine | 404 | 0.584 | 0.490 | 0.696 | 0.259 | 0.610 | 1.13 | 4.15 | 78.4% | 0.100 ng/ml | ▶ ◘ |
| BPF | Bisphenol F | NA | ng/ml | 406 | * | * | * | < LOD | < LOD | 0.228 | 5.91 | 27.6% | 0.200 ng/ml | ▶ ◘ |
| BPF | Bisphenol F | Creatinine | µg/g creatinine | 404 | * | * | * | < LOD | < LOD | 0.773 | 4.47 | 26.7% | 0.200 ng/ml | ▶ ◘ |
| BPS | Bisphenol S | NA | ng/ml | 406 | 0.612 | 0.474 | 0.791 | 0.141 | 0.701 | 1.82 | 6.86 | 75.8% | 0.100 and 0.200 ng/ml** | ▶ ◘ |
| BPS | Bisphenol S | Creatinine | µg/g creatinine | 404 | 0.802 | 0.638 | 1.01 | 0.349 | 0.885 | 1.79 | 8.01 | 76.8% | 0.100 and 0.200 ng/ml** | ▶ ◘ |
| Ethyl paraben | Ethyl paraben | NA | ng/ml | 406 | * | * | * | < LOD | < LOD | 2.45 | 66.7 | 34.6% | 0.200 and 0.500 ng/ml** | ▶ ◘ |
| Ethyl paraben | Ethyl paraben | Creatinine | µg/g creatinine | 404 | * | * | * | < LOD | < LOD | 2.27 | 73.8 | 35.1% | 0.200 and 0.500 ng/ml** | ▶ ◘ |
| Methyl paraben | Methyl paraben | NA | ng/ml | 406 | 13.7 | 9.67 | 19.5 | 2.97 | 18.9 | 78.2 | 389 | 83.3% | 0.500 ng/ml | ▶ ◘ |
| Methyl paraben | Methyl paraben | Creatinine | µg/g creatinine | 404 | 18.4 | 13.4 | 25.2 | 4.05 | 26.0 | 103 | 254 | 83.3% | 0.500 ng/ml | ▶ ◘ |
| Propyl paraben | Propyl paraben | NA | ng/ml | 406 | 2.68 | 1.77 | 4.07 | < LOD | 2.29 | 23.6 | 158 | 66.1% | 0.200 ng/ml | ▶ ◘ |
| Propyl paraben | Propyl paraben | Creatinine | µg/g creatinine | 404 | 3.50 | 2.33 | 5.28 | < LOD | 3.57 | 35.7 | 146 | 65.6% | 0.200 ng/ml | ▶ ◘ |
| Triclocarban | Triclocarban | NA | ng/ml | 406 | * | * | * | < LOD | < LOD | < LOD | 0.301 | 15.5% | 0.100 ng/ml | ▶ ◘ |
| Triclocarban | Triclocarban | Creatinine | µg/g creatinine | 404 | * | * | * | < LOD | < LOD | < LOD | 0.808 | 14.4% | 0.100 ng/ml | ▶ ◘ |
| Triclosan | Triclosan | NA | ng/ml | 406 | * | * | * | < LOD | 0.705 | 6.52 | 528 | 51.0% | 0.200 and 1.000 ng/ml** | ▶ ◘ |
| Triclosan | Triclosan | Creatinine | µg/g creatinine | 404 | * | * | * | < LOD | 1.81 | 9.23 | 758 | 51.8% | 0.200 and 1.000 ng/ml** | ▶ ◘ |
Footnotes
- ▶CARE-LA data were weighted (a statistical method to adjust over-represented and under-represented demographic characteristics in a study sample) so that the summary results adequately reflect the population of California’s Los Angeles County. Unweighted results are available to download on the California Regional Exposure Study, Los Angeles County (CARE-LA) project page.
- **LOD changed during the time that samples were analyzed for this project.
- ◘Butylparaben was tested among only 60 participants. The sample size is not sufficiently large enough to provide weighted summary statistics.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Metals
- Measured in: Blood
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Cadmium | Cadmium | NA | µg/L | 425 | 0.258 | 0.232 | 0.286 | 0.173 | 0.248 | 0.357 | 0.785 | 99.6% | 0.0750 µg/L | ▶ |
| Lead | Lead | NA | µg/dL | 425 | 0.768 | 0.683 | 0.862 | 0.480 | 0.730 | 1.26 | 2.32 | 100% | 0.0250 µg/dL | ▶ |
| Manganese | Manganese | NA | µg/L | 425 | 10.6 | 10.1 | 11.2 | 8.38 | 10.4 | 12.6 | 20.3 | 100% | 0.750 µg/L | ▶ |
| Mercury | Mercury | NA | µg/L | 425 | 0.975 | 0.794 | 1.20 | 0.387 | 1.04 | 2.56 | 6.02 | 92.9% | 0.125 µg/L | ▶ |
Footnotes
- ▶CARE-LA data were weighted (a statistical method to adjust over-represented and under-represented demographic characteristics in a study sample) so that the summary results adequately reflect the population of California’s Los Angeles County. Unweighted results are available to download on the California Regional Exposure Study, Los Angeles County (CARE-LA) project page.
Chemical Group: Metals
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Antimony | Antimony | NA | µg/L | 428 | * | * | * | < LOD | < LOD | 0.0316 | 0.101 | 26.2% | 0.0300 µg/L | ▶ |
| Antimony | Antimony | Creatinine | µg/g creatinine | 426 | * | * | * | < LOD | < LOD | 0.0676 | 0.180 | 26.6% | 0.0300 µg/L | ▶ |
| Arsenic | Arsenic | NA | µg/L | 428 | 8.06 | 6.69 | 9.71 | 3.63 | 7.91 | 16.7 | 67.2 | 100% | 0.100 µg/L | ▶ |
| Arsenic | Arsenic | Creatinine | µg/g creatinine | 426 | 10.6 | 9.06 | 12.3 | 5.16 | 9.14 | 18.8 | 59.7 | 100% | 0.100 µg/L | ▶ |
| Cadmium | Cadmium | NA | µg/L | 428 | 0.153 | 0.130 | 0.182 | 0.0707 | 0.169 | 0.342 | 0.743 | 100% | 0.0100 µg/L | ▶ |
| Cadmium | Cadmium | Creatinine | µg/g creatinine | 426 | 0.199 | 0.175 | 0.227 | 0.115 | 0.187 | 0.338 | 0.691 | 100% | 0.0100 µg/L | ▶ |
| Cobalt | Cobalt | NA | µg/L | 428 | 0.217 | 0.184 | 0.256 | 0.119 | 0.210 | 0.398 | 1.37 | 100% | 0.0100 µg/L | ▶ |
| Cobalt | Cobalt | Creatinine | µg/g creatinine | 426 | 0.284 | 0.251 | 0.321 | 0.154 | 0.262 | 0.528 | 1.18 | 100% | 0.0100 µg/L | ▶ |
| Manganese | Manganese | NA | µg/L | 428 | * | * | * | < LOD | < LOD | < LOD | 0.174 | 15.2% | 0.100 µg/L | ▶ |
| Manganese | Manganese | Creatinine | µg/g creatinine | 426 | * | * | * | < LOD | < LOD | < LOD | 0.611 | 15.4% | 0.100 µg/L | ▶ |
| Mercury | Mercury | NA | µg/L | 428 | 0.202 | 0.159 | 0.256 | 0.0814 | 0.232 | 0.519 | 2.63 | 97.1% | 0.0100 µg/L | ▶ |
| Mercury | Mercury | Creatinine | µg/g creatinine | 426 | 0.262 | 0.218 | 0.314 | 0.143 | 0.277 | 0.516 | 1.73 | 97.3% | 0.0100 µg/L | ▶ |
| Molybdenum | Molybdenum | NA | µg/L | 428 | 36.0 | 30.5 | 42.5 | 20.0 | 39.6 | 79.2 | 160 | 100% | 0.300 µg/L | ▶ |
| Molybdenum | Molybdenum | Creatinine | µg/g creatinine | 426 | 47.1 | 41.7 | 53.2 | 28.5 | 44.9 | 79.7 | 194 | 100% | 0.300 µg/L | ▶ |
| Thallium | Thallium | NA | µg/L | 428 | 0.154 | 0.134 | 0.178 | 0.0850 | 0.169 | 0.305 | 0.527 | 99.8% | 0.0100 µg/L | ▶ |
| Thallium | Thallium | Creatinine | µg/g creatinine | 426 | 0.200 | 0.183 | 0.218 | 0.132 | 0.197 | 0.284 | 0.491 | 100% | 0.0100 µg/L | ▶ |
| Uranium | Uranium | NA | µg/L | 428 | * | * | * | < LOD | < LOD | 0.0193 | 0.116 | 48.6% | 0.0100 µg/L | ▶ |
| Uranium | Uranium | Creatinine | µg/g creatinine | 426 | * | * | * | < LOD | < LOD | 0.0313 | 0.116 | 49.3% | 0.0100 µg/L | ▶ |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- ▶CARE-LA data were weighted (a statistical method to adjust over-represented and under-represented demographic characteristics in a study sample) so that the summary results adequately reflect the population of California’s Los Angeles County. Unweighted results are available to download on the California Regional Exposure Study, Los Angeles County (CARE-LA) project page.
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 425 | * | * | * | <LOD | <LOD | 0.0147 | 0.0554 | 35.7% | 0.0115 ng/mL | ▶ |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 425 | 0.0678 | 0.0589 | 0.0780 | 0.0396 | 0.0558 | 0.0953 | 0.340 | 100% | 0.0114 ng/mL | ▶ |
| PFBS | PFBS | NA | ng/mL | 425 | * | * | * | <LOD | <LOD | <LOD | 0.0357 | 5.5% | 0.0303 ng/mL | ▶ |
| PFDA | PFDA | NA | ng/mL | 425 | * | * | * | <LOD | 0.0795 | 0.164 | 0.321 | 62.3% | 0.0560 ng/mL | ▶ |
| PFDoA | PFDoA | NA | ng/mL | 425 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.110 ng/mL | ▶ |
| PFHpA | PFHpA | NA | ng/mL | 425 | * | * | * | <LOD | 0.0280 | 0.0447 | 0.0981 | 52.0% | 0.0256 ng/mL | ▶ |
| PFHxS | PFHxS | NA | ng/mL | 425 | 0.689 | 0.585 | 0.813 | 0.418 | 0.787 | 1.23 | 2.39 | 98.5% | 0.0177 ng/mL | ▶ |
| PFNA | PFNA | NA | ng/mL | 425 | 0.298 | 0.263 | 0.339 | 0.195 | 0.320 | 0.471 | 1.16 | 96.9% | 0.0424 ng/mL | ▶ |
| PFOA | PFOA | NA | ng/mL | 425 | 1.04 | 0.920 | 1.17 | 0.732 | 1.17 | 1.52 | 3.06 | 99.8% | 0.0606 ng/mL | ▶ |
| PFOS | PFOS | NA | ng/mL | 425 | 2.20 | 1.87 | 2.60 | 1.41 | 2.38 | 3.91 | 8.78 | 98.0% | 0.0615 ng/mL | ▶ |
| PFOSA | PFOSA | NA | ng/mL | 425 | * | * | * | <LOD | <LOD | 0.0152 | 0.0611 | 26.7% | 0.0144 ng/mL | ▶ |
| PFUnDA | PFUnDA | NA | ng/mL | 425 | 0.0721 | 0.0619 | 0.0840 | 0.0336 | 0.0735 | 0.136 | 0.350 | 77.6% | 0.0285 ng/mL | ▶ |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- ▶CARE-LA data were weighted (a statistical method to adjust over-represented and under-represented demographic characteristics in a study sample) so that the summary results adequately reflect the population of California’s Los Angeles County. Unweighted results are available to download on the California Regional Exposure Study, Los Angeles County (CARE-LA) project page.
Chemical Group: Metals
- Measured in: Urine
- Study Group Subset: Speciated arsenic
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Arsenobetaine | Arsenic | NA | µg/L | 414 | 1.14 | 0.813 | 1.60 | 0.179 | 0.952 | 6.03 | 40.7 | 82.4% | 0.100 µg/L | ▶ |
| Arsenobetaine | Arsenic | Creatinine | µg/g creatinine | 412 | 1.46 | 1.05 | 2.03 | 0.256 | 1.14 | 7.55 | 37.9 | 82.4% | 0.100 µg/L | ▶ |
| Arsenocholine | Arsenic | NA | µg/L | 414 | * | * | * | < LOD | < LOD | < LOD | 0.206 | 10.0% | 0.100 µg/L | ▶ |
| Arsenocholine | Arsenic | Creatinine | µg/g creatinine | 412 | * | * | * | < LOD | < LOD | < LOD | 0.528 | 10.2% | 0.100 µg/L | ▶ |
| DMA | Arsenic | NA | µg/L | 414 | 3.47 | 2.95 | 4.08 | 2.03 | 3.60 | 6.41 | 18.1 | 100% | 0.100 µg/L | ▶ |
| DMA | Arsenic | Creatinine | µg/g creatinine | 412 | 4.54 | 4.07 | 5.07 | 2.64 | 4.26 | 6.58 | 13.7 | 100% | 0.100 µg/L | ▶ |
| MMA | Arsenic | NA | µg/L | 414 | 0.480 | 0.422 | 0.546 | 0.275 | 0.515 | 0.840 | 1.56 | 95.0% | 0.100 µg/L | ▶ |
| MMA | Arsenic | Creatinine | µg/g creatinine | 412 | 0.621 | 0.564 | 0.684 | 0.394 | 0.609 | 0.911 | 1.70 | 95.2% | 0.100 µg/L | ▶ |
| As(III) | Arsenic | NA | µg/L | 414 | 0.312 | 0.264 | 0.369 | 0.127 | 0.318 | 0.579 | 2.12 | 83.8% | 0.100 µg/L | ▶ |
| As(III) | Arsenic | Creatinine | µg/g creatinine | 412 | 0.403 | 0.349 | 0.465 | 0.231 | 0.366 | 0.552 | 2.26 | 85.0% | 0.100 µg/L | ▶ |
| As(V) | Arsenic | NA | µg/L | 414 | * | * | * | < LOD | < LOD | < LOD | 0.440 | 22.4% | 0.100 and 0.200 µg/L** | ▶ |
| As(V) | Arsenic | Creatinine | µg/g creatinine | 412 | * | * | * | < LOD | < LOD | < LOD | 1.07 | 22.7% | 0.100 and 0.200 µg/L** | ▶ |
Footnotes
- ▶CARE-LA data were weighted (a statistical method to adjust over-represented and under-represented demographic characteristics in a study sample) so that the summary results adequately reflect the population of California’s Los Angeles County. Unweighted results are available to download on the California Regional Exposure Study, Los Angeles County (CARE-LA) project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- **LOD changed during the time that samples were analyzed for this project.
Chemical Group: Diesel Exhaust
- Measured in: Urine
- Study Group Subset: Adults
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| 6-OHNP | 1-Nitropyrene | Specific-gravity | pg/L^ | 109 | 110 | 89 | 130 | 60 | 120 | 200 | 660 | 90.8% | 9.4 pg/L |
| 8-OHNP | 1-Nitropyrene | Specific-gravity | pg/L^ | 149 | 88 | 76 | 100 | 51 | 91 | 160 | 400 | 87.2% | 11.4 pg/L |
Footnotes
- ^Concentrations were adjusted for specific gravity using a reference value of 1.017 from NHANES 2007-2008.
Project: California Regional Exposure Study, Region 2 (CARE-2)
- Study Group: 359 adults (age 18 and up) living in Riverside, San Bernardino, Imperial, Mono, and Inyo counties
- Sample Collection Date:
Chemical Group: Metals
- Measured in: Blood
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Cadmium | Cadmium | NA | µg/L | 359 | 0.275 | 0.246 | 0.307 | 0.161 | 0.266 | 0.478 | 0.793 | 99.1% | 0.0750 µg/L | ◁ |
| Lead | Lead | NA | µg/dL | 359 | 0.661 | 0.591 | 0.739 | 0.417 | 0.712 | 1.08 | 1.80 | 100% | 0.0250 µg/dL | ◁ |
| Manganese | Manganese | NA | µg/L | 359 | 10.1 | 9.71 | 10.6 | 8.03 | 9.96 | 12.3 | 15.9 | 100% | 0.250 µg/L | ◁ |
| Mercury | Mercury | NA | µg/L | 359 | 0.719 | 0.581 | 0.889 | 0.279 | 0.778 | 1.51 | 6.12 | 94.8% | 0.0750 µg/L | ◁ |
Footnotes
- ◁CARE-2 data from 359 participants were weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Riverside, San Bernardino, Imperial, Mono, and Inyo counties. Unweighted results are available to download on the California Regional Exposure Study, Region 2 (CARE-2) project page.
Chemical Group: Metals
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Antimony | Antimony | NA | µg/L | 357 | * | * | * | < LOD | < LOD | < LOD | 0.343 | 19.2% | 0.0500 µg/L | ▽ |
| Antimony | Antimony | Creatinine | µg/g creatinine | 357 | * | * | * | < LOD | < LOD | < LOD | 0.309 | 19.2% | 0.0500 µg/L | ▽ |
| Arsenic | Arsenic | NA | µg/L | 357 | 6.40 | 5.16 | 7.96 | 2.69 | 6.27 | 11.5 | 42.1 | 100% | 0.100 µg/L | ▽ |
| Arsenic | Arsenic | Creatinine | µg/g creatinine | 357 | 8.40 | 7.10 | 9.94 | 4.02 | 6.86 | 14.2 | 50.4 | 100% | 0.100 µg/L | ▽ |
| Cadmium | Cadmium | NA | µg/L | 357 | 0.172 | 0.145 | 0.205 | 0.0786 | 0.186 | 0.363 | 0.901 | 95.1% | 0.0300 µg/L | ▽ |
| Cadmium | Cadmium | Creatinine | µg/g creatinine | 357 | 0.226 | 0.195 | 0.262 | 0.112 | 0.227 | 0.394 | 1.05 | 95.1% | 0.0300 µg/L | ▽ |
| Cobalt | Cobalt | NA | µg/L | 357 | 0.182 | 0.154 | 0.215 | 0.0927 | 0.200 | 0.360 | 1.05 | 92.9% | 0.0300 µg/L | ▽ |
| Cobalt | Cobalt | Creatinine | µg/g creatinine | 357 | 0.238 | 0.209 | 0.272 | 0.125 | 0.200 | 0.390 | 1.11 | 92.9% | 0.0300 µg/L | ▽ |
| Manganese | Manganese | NA | µg/L | 357 | * | * | * | < LOD | < LOD | < LOD | 0.212 | 15.4% | 0.100 µg/L | ▽ |
| Manganese | Manganese | Creatinine | µg/g creatinine | 357 | * | * | * | < LOD | < LOD | < LOD | 0.555 | 15.4% | 0.100 µg/L | ▽ |
| Mercury | Mercury | NA | µg/L | 357 | 0.165 | 0.138 | 0.197 | 0.0706 | 0.168 | 0.362 | 0.922 | 91.6% | 0.0300 µg/L | ▽ |
| Mercury | Mercury | Creatinine | µg/g creatinine | 357 | 0.216 | 0.184 | 0.254 | 0.104 | 0.213 | 0.402 | 1.34 | 91.6% | 0.0300 µg/L | ▽ |
| Molybdenum | Molybdenum | NA | µg/L | 357 | 33.5 | 28.2 | 39.8 | 18.6 | 35.6 | 64.7 | 168 | 100% | 0.300 µg/L | ▽ |
| Molybdenum | Molybdenum | Creatinine | µg/g creatinine | 357 | 43.9 | 38.8 | 49.7 | 29.3 | 42.9 | 62.9 | 161 | 100% | 0.300 µg/L | ▽ |
| Thallium | Thallium | NA | µg/L | 357 | 0.148 | 0.130 | 0.169 | 0.0884 | 0.158 | 0.257 | 0.472 | >99.9% | 0.0100 µg/L | ▽ |
| Thallium | Thallium | Creatinine | µg/g creatinine | 357 | 0.194 | 0.177 | 0.214 | 0.129 | 0.182 | 0.278 | 0.525 | >99.9% | 0.0100 µg/L | ▽ |
| Uranium | Uranium | NA | µg/L | 357 | * | * | * | < LOD | < LOD | 0.0216 | 0.0805 | 49.6% | 0.0100 µg/L | ▽ |
| Uranium | Uranium | Creatinine | µg/g creatinine | 357 | * | * | * | < LOD | < LOD | 0.0316 | 0.112 | 49.6% | 0.0100 µg/L | ▽ |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- ▽CARE-2 data from 357 participants were weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Riverside, San Bernardino, Imperial, Mono, and Inyo counties. Unweighted results are available to download on the California Regional Exposure Study, Region 2 (CARE-2) project page.
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 358 | * | * | * | <LOD | <LOD | <LOD | 0.0312 | 16.4% | 0.0115 ng/mL | ◀ |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 358 | 0.0344 | 0.0298 | 0.0397 | 0.0178 | 0.0355 | 0.0580 | 0.204 | 81.2% | 0.0114 ng/mL | ◀ |
| PFBS | PFBS | NA | ng/mL | 357 | * | * | * | <LOD | <LOD | <LOD | 0.0379 | 9.8% | 0.0303 ng/mL | ▽ |
| PFDA | PFDA | NA | ng/mL | 358 | * | * | * | <LOD | 0.0768 | 0.144 | 0.252 | 63.3% | 0.0560 ng/mL | ◀ |
| PFDoA | PFDoA | NA | ng/mL | 358 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.01% | 0.110 ng/mL | ◀ |
| PFHpA | PFHpA | NA | ng/mL | 358 | * | * | * | <LOD | <LOD | 0.0536 | 0.101 | 43.6% | 0.0256 ng/mL | ◀ |
| PFHxS | PFHxS | NA | ng/mL | 358 | 0.798 | 0.669 | 0.953 | 0.465 | 0.837 | 1.72 | 3.20 | 99.8% | 0.0177 ng/mL | ◀ |
| PFNA | PFNA | NA | ng/mL | 358 | 0.211 | 0.181 | 0.246 | 0.132 | 0.256 | 0.374 | 0.775 | 89.5% | 0.0424 ng/mL | ◀ |
| PFOA | PFOA | NA | ng/mL | 358 | 0.987 | 0.866 | 1.12 | 0.668 | 1.13 | 1.77 | 2.53 | 98.8% | 0.0606 ng/mL | ◀ |
| PFOS | PFOS | NA | ng/mL | 357 | 2.41 | 2.05 | 2.82 | 1.48 | 2.88 | 4.89 | 7.14 | 98.5% | 0.0615 ng/mL | ▽ |
| PFOSA | PFOSA | NA | ng/mL | 358 | * | * | * | <LOD | <LOD | <LOD | 0.0329 | 14.9% | 0.0144 ng/mL | ◀ |
| PFUnDA | PFUnDA | NA | ng/mL | 358 | * | * | * | <LOD | 0.0416 | 0.0929 | 0.258 | 61.3% | 0.0285 ng/mL | ◀ |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- ◀CARE-2 data from 358 participants were weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Riverside, San Bernardino, Imperial, Mono, and Inyo counties. Unweighted results are available to download on the California Regional Exposure Study, Region 2 (CARE-2) project page.
- ▽CARE-2 data from 357 participants were weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Riverside, San Bernardino, Imperial, Mono, and Inyo counties. Unweighted results are available to download on the California Regional Exposure Study, Region 2 (CARE-2) project page.
Chemical Group: Diesel Exhaust
- Measured in: Urine
- Study Group Subset: Adults
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| 6-OHNP | 1-Nitropyrene | Specific-gravity | pg/L^ | 142 | 150 | 120 | 180 | 83 | 150 | 300 | 960 | 88.7% | 13 pg/L |
| 8-OHNP | 1-Nitropyrene | Specific-gravity | pg/L^ | 155 | 89 | 76 | 100 | 49 | 78 | 160 | 410 | 76.1% | 22 pg/L |
Footnotes
- ^Concentrations were adjusted for specific gravity using a reference value of 1.017 from NHANES 2007-2008.
Chemical Group: Environmental Phenols
- Measured in: Urine
- Study Group Subset: Adults
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Benzophenone-3 | Benzophenone-3 | NA | µg/L | 151 | 18.5 | 13.7 | 25.1 | 5.59 | 18.0 | 50.0 | 493 | 96.0% | 1.00 |
| BPA | Bisphenol A | NA | µg/L | 151 | 0.503 | 0.419 | 0.603 | <LOD | 0.466 | 1.12 | 3.19 | 69.5% | 0.200 |
| BPS | Bisphenol S | NA | µg/L | 151 | * | * | * | <LOD | 0.233 | 0.593 | 2.25 | 64.9% | 0.100 |
| Ethyl paraben | Ethyl paraben | NA | µg/L | 151 | * | * | * | <LOD | <LOD | 2.02 | 69.7 | 35.8% | 0.500 |
| Methyl paraben | Methyl paraben | NA | µg/L | 151 | 15.3 | 10.9 | 21.5 | 3.11 | 12.6 | 79.4 | 535 | 94.0% | 0.500 |
| Propyl paraben | Propyl paraben | NA | µg/L | 151 | * | * | * | <LOD | 1.54 | 14.8 | 223 | 60.3% | 0.200 |
| Triclocarban | Triclocarban | NA | µg/L | 151 | * | * | * | <LOD | <LOD | <LOD | 0.307 | 11.3% | 0.100 |
| Triclosan | Triclosan | NA | µg/L | 151 | * | * | * | <LOD | <LOD | 3.02 | 389 | 45.0% | 1.00 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Project: California Regional Exposure Study, Region 3 (CARE-3)
- Study Group: 90 adults (age 18 and up) living in San Diego and Orange counties
- Sample Collection Date:
Chemical Group: Environmental Phenols
- Measured in: Urine
- Study Group Subset: Adults
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||||
| Benzophenone-3 | Benzophenone-3 | NA | µg/L | 90 | 14.4 | 9.16 | 22.6 | 3.70 | 13.1 | 47.4 | 190 | 90.0% | 0.500 µg/L | ⌂ |
| BPA | Bisphenol A | NA | µg/L | 90 | 0.287 | 0.233 | 0.352 | 0.124 | 0.281 | 0.598 | 0.895 | 82.2% | 0.100 µg/L | ⌂ |
| BPF | Bisphenol F | NA | µg/L | 90 | * | * | * | <LOD | <LOD | 0.573 | 2.03 | 41.1% | 0.200 µg/L | ⌂ |
| BPS | Bisphenol S | NA | µg/L | 90 | * | * | * | <LOD | 0.288 | 0.875 | 2.85 | 64.4% | 0.100 µg/L | ⌂ |
| Butyl paraben | Butyl paraben | NA | µg/L | 90 | * | * | * | <LOD | <LOD | <LOD | 0.114 | 11.1% | 0.100 µg/L | ⌂ |
| Ethyl paraben | Ethyl paraben | NA | µg/L | 90 | * | * | * | <LOD | <LOD | 0.212 | 8.92 | 25.6% | 0.200 µg/L | ⌂ |
| Methyl paraben | Methyl paraben | NA | µg/L | 90 | 8.33 | 5.15 | 13.5 | 1.01 | 9.57 | 57.1 | 152 | 80.0% | 0.500 µg/L | ⌂ |
| Propyl paraben | Propyl paraben | NA | µg/L | 90 | * | * | * | <LOD | <LOD | 13.5 | 42.5 | 50.0% | 0.200 µg/L | ⌂ |
| Triclocarban | Triclocarban | NA | µg/L | 90 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.6% | 0.100 µg/L | ⌂ |
| Triclosan | Triclosan | NA | µg/L | 90 | * | * | * | <LOD | <LOD | <LOD | 1.82 | 18.9% | 1.00 µg/L | ⌂ |
Footnotes
- ⌂Due to the COVID-19 emergency, CARE-3 was stopped early and only 90 people completed all study steps. The results from this small non-representative sample cannot be generalized to the population of San Diego and Orange counties.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Metals
- Measured in: Blood
- Study Group Subset: Adults
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||||
| Cadmium | Cadmium | NA | µg/L | 88 | 0.279 | 0.235 | 0.332 | 0.156 | 0.289 | 0.48 | 0.629 | 95.5% | 0.0750 µg/L | ⌂ |
| Lead | Lead | NA | µg/dL | 88 | 0.690 | 0.606 | 0.785 | 0.474 | 0.706 | 0.900 | 1.42 | 100% | 0.0250 µg/dL | ⌂ |
| Manganese | Manganese | NA | µg/L | 88 | 9.13 | 8.46 | 9.87 | 7.12 | 9.54 | 11.9 | 14.1 | 100% | 0.250 µg/L | ⌂ |
| Mercury | Mercury | NA | µg/L | 88 | 1.03 | 0.809 | 1.30 | 0.500 | 1.16 | 2.34 | 4.04 | 98.7% | 0.0750 µg/L | ⌂ |
Footnotes
- ⌂Due to the COVID-19 emergency, CARE-3 was stopped early and only 90 people completed all study steps. The results from this small non-representative sample cannot be generalized to the population of San Diego and Orange counties.
Chemical Group: Metals
- Measured in: Urine
- Study Group Subset: Adults
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||||
| Antimony | Antimony | NA | µg/L | 90 | * | * | * | <LOD | <LOD | <LOD | 0.0558 | 20.0% | 0.0300 µg/L | ⌂ |
| Arsenic | Arsenic | NA | µg/L | 90 | 6.13 | 4.57 | 8.21 | 2.46 | 4.44 | 18.5 | 40.0 | 100% | 0.100 µg/L | ⌂ |
| Cadmium | Cadmium | Creatinine | µg/g creatinine | 90 | 0.240 | 0.201 | 0.287 | 0.123 | 0.231 | 0.403 | 0.714 | 91.1% | 0.0300 µg/L | ⌂ |
| Cobalt | Cobalt | NA | µg/L | 90 | 0.171 | 0.133 | 0.220 | 0.0715 | 0.182 | 0.319 | 0.846 | 92.2% | 0.0300 µg/L | ⌂ |
| Manganese | Manganese | NA | µg/L | 90 | * | * | * | <LOD | <LOD | <LOD | 0.132 | 18.9% | 0.100 µg/L | ⌂ |
| Mercury | Mercury | NA | µg/L | 90 | 0.156 | 0.121 | 0.201 | 0.0667 | 0.156 | 0.369 | 0.643 | 88.9% | 0.0300 µg/L | ⌂ |
| Molybdenum | Molybdenum | NA | µg/L | 90 | 24.5 | 19.8 | 30.3 | 12.1 | 26.2 | 58.1 | 85.2 | 100% | 0.300 µg/L | ⌂ |
| Thallium | Thallium | NA | µg/L | 90 | 0.108 | 0.0909 | 0.129 | 0.0607 | 0.119 | 0.208 | 0.273 | 98.9% | 0.0100 µg/L | ⌂ |
| Uranium | Uranium | NA | µg/L | 90 | * | * | * | <LOD | <LOD | 0.0164 | 0.0326 | 40.0% | 0.0100 µg/L | ⌂ |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- ⌂Due to the COVID-19 emergency, CARE-3 was stopped early and only 90 people completed all study steps. The results from this small non-representative sample cannot be generalized to the population of San Diego and Orange counties.
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
- Study Group Subset: Adults
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 89 | * | * | * | <LOD | <LOD | <LOD | 0.0250 | 16.9% | 0.0115 ng/mL | ⌂ |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 88 | 0.0363 | 0.0266 | 0.0494 | <LOD | 0.0332 | 0.082 | 0.238 | 65.9% | 0.0114 ng/mL | ⌂ |
| PFBS | PFBS | NA | ng/mL | 79 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.5% | 0.0303 ng/mL | ⌂ |
| PFDA | PFDA | NA | ng/mL | 89 | 0.0942 | 0.0802 | 0.111 | <LOD | 0.0926 | 0.174 | 0.234 | 67.4% | 0.0560 ng/mL | ⌂ |
| PFDoA | PFDoA | NA | ng/mL | 80 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.0% | 0.110 ng/mL | ⌂ |
| PFHpA | PFHpA | NA | ng/mL | 82 | * | * | * | <LOD | <LOD | 0.0377 | 0.0690 | 39.0% | 0.0256 ng/mL | ⌂ |
| PFHxS | PFHxS | NA | ng/mL | 89 | 0.670 | 0.517 | 0.868 | 0.393 | 0.796 | 1.33 | 2.69 | 97.8% | 0.0177 ng/mL | ⌂ |
| PFNA | PFNA | NA | ng/mL | 89 | 0.295 | 0.245 | 0.356 | 0.216 | 0.335 | 0.524 | 0.762 | 92.1% | 0.0424 ng/mL | ⌂ |
| PFOA | PFOA | NA | ng/mL | 89 | 0.901 | 0.733 | 1.11 | 0.702 | 1.03 | 1.48 | 2.21 | 95.5% | 0.0606 ng/mL | ⌂ |
| PFOS | PFOS | NA | ng/mL | 89 | 1.75 | 1.34 | 2.28 | 1.01 | 2.30 | 3.92 | 5.22 | 95.5% | 0.0615 ng/mL | ⌂ |
| PFOSA | PFOSA | NA | ng/mL | 89 | * | * | * | <LOD | <LOD | <LOD | 0.0328 | 20.2% | 0.0144 ng/mL | ⌂ |
| PFUnDA | PFUnDA | NA | ng/mL | 89 | 0.0804 | 0.066 | 0.098 | 0.0372 | 0.0839 | 0.161 | 0.286 | 80.9% | 0.0285 ng/mL | ⌂ |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- ⌂Due to the COVID-19 emergency, CARE-3 was stopped early and only 90 people completed all study steps. The results from this small non-representative sample cannot be generalized to the population of San Diego and Orange counties.
Project: California Teachers Study (CTS)
- Study Group: 2,869 female professional school employees
- Sample Collection Date:
Chemical Group: Pesticidas Organoclorados
- Measured in: Serum
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | Lipids | ng/g lipid | 793 | 5.21 | 4.88 | 5.57 | 2.79 | 5.24 | 9.66 | 25.3 | 84.5% | 0.015 ng/mL |
| DDE (para,para) | DDT (para,para) and/or DDE (para,para) | Lipids | ng/g lipid | 793 | 301 | 283 | 320 | 159 | 298 | 540 | 1360 | 100% | 0.015 ng/mL |
| DDT (ortho,para) | DDT (ortho,para) | Lipids | ng/g lipid | 793 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.3% | 0.031 ng/mL |
| DDT (para,para) | DDT (para,para) | Lipids | ng/g lipid | 793 | 1.94 | 1.87 | 2.02 | <LOD | 1.84 | 2.58 | 5.47 | 67.7% | 0.015 ng/mL |
| Hexachlorobenzene (HCB) | HCB | Lipids | ng/g lipid | 793 | 12 | 11.7 | 12.2 | 9.75 | 11.9 | 14.3 | 20.8 | 100% | 0.015 ng/mL |
| Oxychlordane | Oxychlordane | Lipids | ng/g lipid | 793 | 8.34 | 7.95 | 8.75 | 5.52 | 8.63 | 13 | 23.6 | 98.1% | 0.015 ng/mL |
| trans-Nonachlor | t-Nonachlor | Lipids | ng/g lipid | 793 | 15.3 | 14.6 | 16 | 10.1 | 14.8 | 23.4 | 49.4 | 99.9% | 0.015 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Et-PFOSA-AcOH | EtPFOSAAcOH | NA | ng/mL | 1759 | 0.031 | 0.029 | 0.032 | 0.015 | 0.03 | 0.06 | 0.2 | 84.5% | 0.011 |
| Me-PFOSA-AcOH | MePFOSAAcOH | NA | ng/mL | 1759 | 0.2 | 0.19 | 0.21 | 0.1 | 0.2 | 0.41 | 1.3 | 98.4% | 0.013 |
| PFBS | PFBS | NA | ng/mL | 614 | *,# | * | * | <LOD | <LOD | <LOD | 0.067 | 18.4% | 0.022 |
| PFDA | PFDA | NA | ng/mL | 1759 | 0.22 | 0.21 | 0.23 | 0.15 | 0.23 | 0.35 | 0.67 | 94.7% | 0.032 |
| PFDoA | PFDoA | NA | ng/mL | 1737 | * | * | * | <LOD | <LOD | <LOD | 0.093 | 10.8% | 0.036 |
| PFHpA | PFHpA | NA | ng/mL | 1759 | 0.054 | 0.052 | 0.057 | <LOD | 0.054 | 0.11 | 0.28 | 74% | 0.015 |
| PFHxS | PFHxS | NA | ng/mL | 1759 | 1.62 | 1.56 | 1.68 | 1.04 | 1.58 | 2.50 | 6.24 | 99.9% | 0.012 |
| PFNA | PFNA | NA | ng/mL | 1719 | 0.92 | 0.89 | 0.95 | 0.67 | 0.95 | 1.3 | 2.3 | 99.7% | 0.014 |
| PFOA | PFOA | NA | ng/mL | 1759 | 2.46 | 2.39 | 2.53 | 1.69 | 2.5 | 3.63 | 6.22 | 99.9% | 0.029 |
| PFOS | PFOS | NA | ng/mL | 1759 | 6.8 | 6.56 | 7.04 | 4.57 | 7.14 | 10.9 | 19.5 | 99.8% | 0.083 |
| PFOSA | PFOSA | NA | ng/mL | 1597 | 0.036 | 0.034 | 0.039 | <LOD | 0.036 | 0.075 | 0.25 | 74.1% | 0.01 |
| PFUnDA | PFUnDA | NA | ng/mL | 1759 | 0.13 | 0.12 | 0.13 | 0.081 | 0.14 | 0.23 | 0.42 | 96.8% | 0.01 |
Footnotes
- # As of March 2013, PFBuS is no longer measured due to instrumental background interference.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: éteres Difenílicos Polibromados (PBDEs)
- Measured in: Serum
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| BDE 017 | BDE 17 | Lipids | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.2% | 0.006 ng/mL |
| BDE 028 | BDE 28 | Lipids | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | 1.96 | 4.73 | 42.9% | 0.008 ng/mL |
| BDE 047 | BDE 47 | Lipids | ng/g lipid | 1980 | 14.1 | 13.6 | 14.7 | 7.22 | 13.1 | 25.3 | 73.5 | 86.4% | 0.024 ng/mL |
| BDE 066 | BDE 66 | Lipids | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.05% | 0.007 ng/mL |
| BDE 085 | BDE 85 | Lipids | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | 1.87 | 7.8% | 0.002 ng/mL |
| BDE 099 | BDE 99 | Lipids | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | 5 | 16 | 44.3% | 0.018 ng/mL |
| BDE 100 | BDE 100 | Lipids | ng/g lipid | 1980 | 2.62 | 2.5 | 2.73 | 1.19 | 2.31 | 4.71 | 15.7 | 75.9% | 0.004 ng/mL |
| BDE 153 | BDE 153 | Lipids | ng/g lipid | 1980 | 5.6 | 5.34 | 5.85 | 2.66 | 4.75 | 9.48 | 43.1 | 77% | 0.009 ng/mL |
| BDE 154 | BDE 154 | Lipids | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.9% | 0.007 ng/mL |
| BDE 183 | BDE 183 | Lipids | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.7% | 0.007 ng/mL |
| BDE 196 | BDE 196 | Lipids | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2% | 0.003 ng/mL |
| BDE 197 | BDE 197 | Lipids | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | 3.58 | 8.4% | 0.005 ng/mL |
| BDE 201 | BDE 201 | Lipids | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.5% | 0.005 ng/mL |
| BDE 202 | BDE 202 | Lipids | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.9% | 0.005 ng/mL |
| BDE 203 | BDE 203 | Lipids | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.005 ng/mL |
| BDE 206 | BDE 206 | Lipids | ng/g lipid | 1862 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.3% | 0.004 ng/mL |
| BDE 207 | BDE 207 | Lipids | ng/g lipid | 1857 | * | * | * | <LOD | <LOD | <LOD | 4.56 | 9.3% | 0.006 ng/mL |
| BDE 208 | BDE 208 | Lipids | ng/g lipid | 1814 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.7% | 0.003 ng/mL |
| BDE 209 | BDE 209 | Lipids | ng/g lipid | 1797 | * | * | * | <LOD | <LOD | <LOD | 33.3 | 8.7% | 0.053 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Bifenilos Policlorados (PCBs)
- Measured in: Serum
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| PCB 066 | PCB 66 | Lipids | ng/g lipid | 793 | * | * | * | <LOD | <LOD | 1.68 | 3.07 | 39.8% | 0.015 ng/mL |
| PCB 074 | PCB 74 | Lipids | ng/g lipid | 793 | 5.96 | 5.67 | 6.26 | 3.84 | 6.43 | 9.53 | 17.7 | 96.5% | 0.015 ng/mL |
| PCB 099 | PCB 99 | Lipids | ng/g lipid | 793 | 3.11 | 2.97 | 3.27 | 2.01 | 3.07 | 4.82 | 9.73 | 90.4% | 0.015 ng/mL |
| PCB 101 | PCB 101 | Lipids | ng/g lipid | 793 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.3% | 0.015 ng/mL |
| PCB 105 | PCB 105 | Lipids | ng/g lipid | 793 | * | * | * | <LOD | 1.46 | 2.02 | 4.39 | 53% | 0.015 ng/mL |
| PCB 118 | PCB 118 | Lipids | ng/g lipid | 793 | 6.5 | 6.18 | 6.83 | 4.09 | 6.41 | 10.4 | 22 | 99% | 0.015 ng/mL |
| PCB 138 | PCB 138 | Lipids | ng/g lipid | 793 | 12.9 | 12.3 | 13.5 | 8.39 | 13.5 | 20.5 | 37.1 | 99.5% | 0.015 ng/mL |
| PCB 153 | PCB 153 | Lipids | ng/g lipid | 793 | 28.7 | 27.5 | 30 | 19.5 | 30.1 | 43.6 | 72.9 | 100% | 0.015 ng/mL |
| PCB 156 | PCB 156 | Lipids | ng/g lipid | 793 | 4.92 | 4.72 | 5.12 | 3.55 | 5.22 | 7.23 | 11.8 | 96.7% | 0.015 ng/mL |
| PCB 170 | PCB 170 | Lipids | ng/g lipid | 793 | 9.18 | 8.82 | 9.55 | 6.68 | 9.68 | 13.5 | 20.7 | 99.4% | 0.015 ng/mL |
| PCB 180 | PCB 180 | Lipids | ng/g lipid | 793 | 31.5 | 30.3 | 32.9 | 22.4 | 33.3 | 48.4 | 76.8 | 100% | 0.015 ng/mL |
| PCB 183 | PCB 183 | Lipids | ng/g lipid | 793 | 2.37 | 2.27 | 2.47 | 1.65 | 2.4 | 3.5 | 5.98 | 82% | 0.015 ng/mL |
| PCB 187 | PCB 187 | Lipids | ng/g lipid | 793 | 7.25 | 6.92 | 7.59 | 4.83 | 7.65 | 11.04 | 20.2 | 98.4% | 0.015 ng/mL |
| PCB 194 | PCB 194 | Lipids | ng/g lipid | 793 | 7.52 | 7.23 | 7.83 | 5.37 | 7.83 | 11.09 | 17.88 | 99.6% | 0.015 ng/mL |
| PCB 203 | PCB 203 | Lipids | ng/g lipid | 793 | 6.47 | 6.17 | 6.78 | 4.36 | 6.75 | 10.14 | 16.71 | 97.2% | 0.015 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Project: Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS)
- Study Group: 49 Children aged 5 years old
- Sample Collection Date: -
Chemical Group: Ftalatos
- Measured in: Urine
- Study Group Subset: Children
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| MEP | Diethyl phthalate (DEP) | NA | μg/L | 49 | 85 | 63.1 | 115 | 41.3 | 70.0 | 211 | 403 | 100% | 8.0 |
| MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | NA | μg/L | 49 | 46.9 | 37.0 | 59.4 | 26.8 | 49.0 | 75.2 | 115 | 100% | 2.0 |
Project: East Bay Diesel Exposure Project (EBDEP)
- Study Group: 80 East Bay residents (40 child-parent pairs)
- Sample Collection Date: -
Chemical Group: Diesel Exhaust
- Measured in: Urine
- Study Group Subset: Children
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Number of Samples | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||||
| 6-OHNP | 1-Nitropyrene | Specific-gravity | pg/L^ | 40 | 155 | 150 | 110 | 200 | 63 | 170 | 330 | 1100 | 94.2% | 15.5 pg/L | ♢ |
| 8-OHNP | 1-Nitropyrene | Specific-gravity | pg/L^ | 40 | 168 | 130 | 100 | 170 | 61 | 130 | 260 | 740 | 95.2% | 21.2 pg/L | ♢ |
Footnotes
- ^Concentrations were adjusted for specific gravity using a reference value of 1.017 from NHANES 2007-2008.
- ♢SAPEP collected multiple urine samples from study participants. The geometric means were estimated using random effects models to account for multiple samples per participant. Percentiles and detection frequencies were not adjusted for multiple samples per participant.
Chemical Group: Diesel Exhaust
- Measured in: Urine
- Study Group Subset: Adults
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Number of Samples | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||||
| 6-OHNP | 1-Nitropyrene | Specific-gravity | pg/L^ | 38 | 138 | 240 | 180 | 310 | 130 | 240 | 540 | 1500 | 97.8% | 15.5 pg/L | ♢ Δ |
| 8-OHNP | 1-Nitropyrene | Specific-gravity | pg/L^ | 40 | 150 | 150 | 120 | 190 | 82 | 160 | 290 | 730 | 94.7% | 21.2 pg/L | ♢ |
Footnotes
- ^Concentrations were adjusted for specific gravity using a reference value of 1.017 from NHANES 2007-2008.
- ♢SAPEP collected multiple urine samples from study participants. The geometric means were estimated using random effects models to account for multiple samples per participant. Percentiles and detection frequencies were not adjusted for multiple samples per participant.
- ΔTwo samples were damaged during processing and could not be tested.
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
Chemical Group: Environmental Phenols
- Measured in: Urine
- Study Group Subset: Firefighters
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Benzophenone-3 | Benzophenone-3 | NA | µg/L | 101 | 78.5 | 58.3 | 106 | 27.0 | 79.3 | 186 | 867 | 100% | 1.00 |
| BPA | Bisphenol A | NA | µg/L | 101 | 1.58 | 1.25 | 1.99 | 0.718 | 1.53 | 3.16 | 11.9 | 94.1% | 0.20 |
| Butyl paraben | Butyl paraben | NA | µg/L | 101 | * | * | * | <LOD | <LOD | 0.68 | 5.9 | 44.6% | 0.50 |
| Ethyl paraben | Ethyl paraben | NA | µg/L | 101 | * | * | * | <LOD | <LOD | 2.52 | 56.5 | 35.6% | 1.0 |
| Methyl paraben | Methyl paraben | NA | μg/L | 101 | 46.9 | 34.2 | 64.3 | 19.6 | 48.0 | 108 | 687 | 98.0% | 1.0 |
| Propyl paraben | Propyl paraben | NA | μg/L | 101 | * | * | * | <LOD | 2.96 | 19.0 | 135 | 61.4% | 1.0 |
| Triclosan | Triclosan | NA | μg/L | 101 | 20.2 | 13.5 | 30.2 | 3.00 | 19.6 | 103 | 563 | 99.0% | 0.50 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Herbicides
- Measured in: Urine
- Study Group Subset: Firefighters
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| 2,4-D | 2,4-D | NA | μg/L | 101 | 0.27 | 0.21 | 0.34 | 0.13 | 0.28 | 0.51 | 1.46 | 90.1% | 0.050 |
| 2,4,5-T | 2,4,5-T | NA | μg/L | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.050 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Metals
- Measured in: Blood
- Study Group Subset: Firefighters
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of detection (LOD) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Cadmium | Cadmium | NA | μg/L | 101 | 0.19 | 0.18 | 0.21 | 0.15 | 0.20 | 0.24 | 0.35 | 78.2% | 0.15 |
| Lead | Lead | NA | μg/dL | 101 | 0.957 | 0.872 | 1.05 | 0.690 | 0.950 | 1.22 | 2.01 | 100% | 0.02 |
| Manganese | Manganese | NA | μg/L | 101 | 7.61 | 7.26 | 7.98 | 6.50 | 7.70 | 8.79 | 11.4 | 100% | 0.54 |
| Mercury | Mercury | NA | μg/L | 101 | 2.79 | 2.36 | 3.30 | 1.82 | 2.90 | 5.48 | 9.79 | 100% | 0.06 |
Chemical Group: Metals
- Measured in: Urine
- Study Group Subset: Firefighters
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| Arsenic | Arsenic | NA | μg/L | 101 | 10.8 | 9.03 | 12.9 | 6.05 | 10.4 | 21.0 | 34.9 | 100% | 0.158 |
| Cadmium | Cadmium | Creatinine | μg/g creatinine | 101 | 0.145 | 0.132 | 0.160 | <LOD | 0.138 | 0.190 | 0.277 | 69.7% | 0.105 μg/L |
| Manganese | Manganese | NA | μg/L | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 9.1% | 0.184 |
| Mercury | Mercury | NA | μg/L | 101 | 0.455 | 0.382 | 0.542 | 0.221 | 0.447 | 0.914 | 1.28 | 100% | 0.0522 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Pesticidas Organoclorados
- Measured in: Serum
- Study Group Subset: Firefighters
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| beta-Hexachlorocyclohexane (beta-HCH) | beta-HCH | Lipids | ng/g lipid | 101 | 2.19 | 2.00 | 2.41 | 1.68 | 2.23 | 2.83 | 4.64 | 97.0% | 0.005 ng/mL |
| DDE (para,para) | para,para-DDT and/or para,para-DDE | Lipids | ng/g lipid | 101 | 177 | 161 | 196 | 125 | 182 | 245 | 394 | 100% | 0.009 ng/mL |
| DDT (ortho,para) | ortho,para-DDT | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.0% | 0.005 ng/mL |
| DDT (para,para) | para,para-DDT | Lipids | ng/g lipid | 101 | 1.34 | 1.20 | 1.50 | <LOD | 1.43 | 2.07 | 3.08 | 74.3% | 0.005 ng/mL |
| Hexachlorobenzene (HCB) | HCB | Lipids | ng/g lipid | 101 | 11.8 | 11.3 | 12.4 | 10.3 | 11.7 | 13.2 | 17.6 | 100% | 0.007 ng/mL |
| Oxychlordane | Chlordane | Lipids | ng/g lipid | 101 | 4.08 | 3.64 | 4.56 | 2.73 | 4.31 | 5.80 | 9.63 | 99.0% | 0.005 ng/mL |
| trans-Nonachlor | Chlordane | Lipids | ng/g lipid | 101 | 7.32 | 6.57 | 8.15 | 5.07 | 7.32 | 10.2 | 16.6 | 100% | 0.005 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Pesticidas Organofosfatos
- Measured in: Urine
- Study Group Subset: Firefighters
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| IMPY | Diazinon | NA | μg/L | 101 | 0.16 | 0.12 | 0.20 | <LOD | 0.18 | 0.42 | 1.2 | 66.3% | 0.050 |
| TCPy | Chlorpyrifos | NA | μg/L | 101 | 1.78 | 1.47 | 2.15 | 0.823 | 1.96 | 3.32 | 10.4 | 89.1% | 0.50 |
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
- Study Group Subset: Firefighters
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of detection (LOD) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Et-PFOSA-AcOH | EtPFOSAAcOH | NA | ng/mL | 101 | 0.016 | 0.014 | 0.018 | <LOD | 0.016 | 0.023 | 0.060 | 65.3% | 0.011 |
| Me-PFOSA-AcOH | MePFOSAAcOH | NA | ng/mL | 101 | 0.16 | 0.13 | 0.18 | 0.086 | 0.14 | 0.24 | 0.61 | 100% | 0.013 |
| PFBS | PFBS | NA | ng/mL | 101 | * | * | * | <LOD | <LOD | <LOD | 0.020 | 6.9% | 0.02 |
| PFDA | PFDA | NA | ng/mL | 101 | 0.899 | 0.783 | 1.03 | 0.512 | 0.721 | 1.72 | 2.63 | 100% | 0.032 |
| PFDoA | PFDoA | NA | ng/mL | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.040 |
| PFHpA | PFHpA | NA | ng/mL | 101 | 0.13 | 0.11 | 0.15 | 0.06 | 0.12 | 0.22 | 0.63 | 75.2% | 0.059 |
| PFHxS | PFHxS | NA | ng/mL | 101 | 2.26 | 2 | 2.54 | 1.61 | 2.27 | 3.13 | 4.64 | 100% | 0.012 |
| PFNA | PFNA | NA | ng/mL | 101 | 1.15 | 1.06 | 1.25 | 0.888 | 1.13 | 1.49 | 2.21 | 100% | 0.075 |
| PFOA | PFOA | NA | ng/mL | 101 | 3.75 | 3.37 | 4.17 | 2.96 | 3.86 | 4.89 | 9.54 | 100% | 0.301 |
| PFOS | PFOS | NA | ng/mL | 101 | 12.5 | 11.3 | 13.8 | 10.1 | 12.7 | 16.8 | 24.7 | 100% | 0.083 |
| PFOSA | PFOSA | NA | ng/mL | 101 | 0.032 | 0.027 | 0.037 | 0.019 | 0.029 | 0.050 | 0.151 | 95.0% | 0.009 |
| PFUnDA | PFUnDA | NA | ng/mL | 101 | 0.24 | 0.21 | 0.27 | 0.17 | 0.26 | 0.37 | 0.53 | 100% | 0.010 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Ftalatos
- Measured in: Urine
- Study Group Subset: Firefighters
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| MBzP | Benzylbutyl phthalate (BzBP) | NA | μg/L | 101 | 8.18 | 6.56 | 10.2 | 3.93 | 7.76 | 14.9 | 41.3 | 100% | 0.25 |
| MCHP | Dicyclohexyl phthalate (DCHP) | NA | μg/L | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.0% | 0.50 |
| MCPP | Di-n-octyl phthalate (DnOP) | NA | μg/L | 101 | 1.88 | 1.46 | 2.42 | 0.819 | 1.69 | 4.07 | 21.1 | 98.0% | 0.125 |
| MECPP | Di-2-ethylhexyl phthalate (DEHP) | NA | μg/L | 101 | 12.3 | 10.1 | 14.9 | 5.89 | 12.4 | 23.2 | 58.3 | 100% | 0.50 |
| MEP | Diethyl phthalate (DEP) | NA | μg/L | 101 | 52.9 | 38.1 | 73.4 | 20.6 | 46.6 | 168 | 740 | 79.2% | 8.0 |
| MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | NA | μg/L | 101 | 10.6 | 8.83 | 12.8 | 5.69 | 10.6 | 20.2 | 40.6 | 97.0% | 2.0 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: éteres Difenílicos Polibromados (PBDEs)
- Measured in: Serum
- Study Group Subset: Firefighters
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| BDE 017 | BDE 17 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.003 ng/mL |
| BDE 028 | BDE 28 | Lipids | ng/g lipid | 101 | 1.70 | 1.50 | 1.93 | 1.17 | 1.63 | 2.38 | 5.09 | 97.0% | 0.003 ng/mL |
| BDE 047 | BDE 47 | Lipids | ng/g lipid | 101 | 32.2 | 27.8 | 37.5 | 19.3 | 29.9 | 47.9 | 150 | 99.0% | 0.038 ng/mL |
| BDE 066 | BDE 66 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | 0.635 | 5.9% | 0.003 ng/mL |
| BDE 085 | BDE 85 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | 0.655 | 1.82 | 34.7% | 0.003 ng/mL |
| BDE 099 | BDE 99 | Lipids | ng/g lipid | 101 | 6.19 | 5.35 | 7.17 | 3.54 | 5.79 | 9.12 | 22.6 | 90.1% | 0.017 ng/mL |
| BDE 100 | BDE 100 | Lipids | ng/g lipid | 101 | 5.68 | 4.77 | 6.75 | 3.31 | 5.14 | 8.14 | 32.7 | 98.0% | 0.005 ng/mL |
| BDE 153 | BDE 153 | Lipids | ng/g lipid | 101 | 15.4 | 12.9 | 18.2 | 9.01 | 12.9 | 21.1 | 63.1 | 100% | 0.005 ng/mL |
| BDE 154 | BDE 154 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | 2.71 | 19.8% | 0.007 ng/mL |
| BDE 183 | BDE 183 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.0% | 0.007 ng/mL |
| BDE 196 | BDE 196 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.007 ng/mL |
| BDE 197 | BDE 197 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | 1.25 | 1.93 | 3.84 | 62.4% | 0.007 ng/mL |
| BDE 201 | BDE 201 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.0% | 0.007 ng/mL |
| BDE 202 | BDE 202 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.007 ng/mL |
| BDE 203 | BDE 203 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.007 ng/mL |
| BDE 206 | BDE 206 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | 1.99 | 11.9% | 0.009 ng/mL |
| BDE 207 | BDE 207 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | 1.31 | 1.72 | 4.53 | 50.5% | 0.009 ng/mL |
| BDE 208 | BDE 208 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | 1.59 | 7.9% | 0.009 ng/mL |
| BDE 209 | BDE 209 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | 28.3 | 93.7 | 28.7% | 0.150 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Bifenilos Policlorados (PCBs)
- Measured in: Serum
- Study Group Subset: Firefighters
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| PCB 066 | PCB 66 | Lipids | ng/g lipid | 101 | 1.17 | 1.09 | 1.25 | <LOD | 1.19 | 1.41 | 1.88 | 74.3% | 0.007 ng/mL |
| PCB 074 | PCB 74 | Lipids | ng/g lipid | 101 | 1.77 | 1.61 | 1.95 | 1.33 | 1.73 | 2.33 | 4.02 | 96.0% | 0.005 ng/mL |
| PCB 099 | PCB 99 | Lipids | ng/g lipid | 101 | 1.76 | 1.61 | 1.93 | 1.34 | 1.74 | 2.32 | 3.65 | 98.0% | 0.005 ng/mL |
| PCB 101 | PCB 101 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | 1.09 | 1.43 | 1.89 | 50.5% | 0.008 ng/mL |
| PCB 105 | PCB 105 | Lipids | ng/g lipid | 101 | * | * | * | <LOD | <LOD | 0.848 | 1.25 | 45.5% | 0.005 ng/mL |
| PCB 118 | PCB 118 | Lipids | ng/g lipid | 101 | 2.66 | 2.46 | 2.87 | 2.15 | 2.75 | 3.25 | 5.11 | 99.0% | 0.006 ng/mL |
| PCB 138 | PCB 138 | Lipids | ng/g lipid | 101 | 5.53 | 4.98 | 6.15 | 3.55 | 5.54 | 8.04 | 11.9 | 100% | 0.005 ng/mL |
| PCB 153 | PCB 153 | Lipids | ng/g lipid | 101 | 12.2 | 10.8 | 13.7 | 8.18 | 12.9 | 18.9 | 29.8 | 100% | 0.005 ng/mL |
| PCB 156 | PCB 156 | Lipids | ng/g lipid | 101 | 1.84 | 1.61 | 2.09 | 1.21 | 1.88 | 3.09 | 5.23 | 88.1% | 0.005 ng/mL |
| PCB 170 | PCB 170 | Lipids | ng/g lipid | 101 | 3.64 | 3.16 | 4.19 | 2.21 | 3.85 | 5.95 | 10.3 | 97.0% | 0.005 ng/mL |
| PCB 180 | PCB 180 | Lipids | ng/g lipid | 101 | 13.4 | 11.7 | 15.4 | 8.44 | 14.7 | 22.4 | 37.7 | 100% | 0.006 ng/mL |
| PCB 183 | PCB 183 | Lipids | ng/g lipid | 101 | 1.03 | 0.930 | 1.15 | <LOD | 1.04 | 1.51 | 2.33 | 67.3% | 0.005 ng/mL |
| PCB 187 | PCB 187 | Lipids | ng/g lipid | 101 | 2.99 | 2.61 | 3.42 | 1.87 | 2.94 | 5.32 | 7.84 | 97.0% | 0.005 ng/mL |
| PCB 194 | PCB 194 | Lipids | ng/g lipid | 101 | 3.37 | 2.89 | 3.93 | 1.91 | 3.38 | 6.04 | 11.4 | 98.0% | 0.005 ng/mL |
| PCB 203 | PCB 203 | Lipids | ng/g lipid | 101 | 3.37 | 2.92 | 3.89 | 1.91 | 3.83 | 6.30 | 9.37 | 98.0% | 0.005 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Hidrocarburos Aromáticos Policíclicos (PAHs)
- Measured in: Urine
- Study Group Subset: Firefighters
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| 1-NAP | Naphthalene | NA | ng/L | 101 | 1290 | 1030 | 1610 | 613 | 1300 | 2210 | 8270 | 100% | 25.0 |
| 1-PHEN | Phenanthrene | NA | ng/L | 101 | 120 | 103 | 138 | 75.0 | 119 | 196 | 455 | 100% | 10.0 |
| 1-PYR | Pyrene | NA | ng/L | 101 | 87.2 | 72.8 | 105 | 50.2 | 84.2 | 141 | 457 | 95.1% | 20.0 |
| 2-FLUO | Fluorene | NA | ng/L | 101 | 172 | 149 | 198 | 98.4 | 185 | 297 | 510 | 100% | 20.0 |
| 2-NAP | Naphthalene | NA | ng/L | 101 | 3190 | 2690 | 3770 | 2000 | 3060 | 4830 | 11300 | 100% | 20.0 |
| 2-PHEN | Phenanthrene | NA | ng/L | 101 | 67.1 | 59.5 | 75.7 | 41.1 | 64.8 | 97.9 | 204 | 100% | 10.0 |
| 3-FLUO | Fluorene | NA | ng/L | 101 | 83.5 | 70.5 | 98.9 | 44.8 | 85.8 | 148 | 365 | 96.0% | 20.0 |
| 3-PHEN | Phenanthrene | NA | ng/L | 101 | 88.4 | 75.7 | 103 | 51.2 | 94.1 | 140 | 367 | 100% | 10.0 |
| 9-FLUO | Fluorene | NA | ng/L | 101 | 278 | 236 | 327 | 162 | 279 | 453 | 1110 | 100% | 37.0 |
Chemical Group: Pesticidas Piretroides
- Measured in: Urine
- Study Group Subset: Firefighters
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| 3-Phenoxybenzoic acid (3-PBA) | Cyhalothrin, cypermethrin, deltamethrin, fenpropathrin, permethrin, and/or tralomethrin | NA | μg/L | 101 | 0.54 | 0.43 | 0.67 | 0.28 | 0.51 | 0.99 | 3.7 | 98.0% | 0.050 |
| 4-Fluoro-3-phenoxybenzoic acid (4F-3-PBA) | Cyfluthrin | NA | ng/mL | 101 | * | * | * | <LOD | <LOD | <LOD | 0.063 | 10.9% | 0.050 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Project: Markers of Autism Risk in Babies–Learning Early Signs (MARBLES)
- Study Group: 15 Pregnant women who have a biological child with autism spectrum disorder
- Sample Collection Date: -
Chemical Group: Ftalatos
- Measured in: Urine
- Study Group Subset: Pregnant women_measurement 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| MEP | Diethyl phthalate (DEP) | NA | μg/L | 15 | 62.4 | 32.2 | 121 | -- | 52.6 | -- | -- | 100% | 8.0 |
| MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | NA | μg/L | 15 | 21.9 | 14.4 | 33.5 | -- | 21.3 | -- | -- | 100% | 2.0 |
Chemical Group: Ftalatos
- Measured in: Urine
- Study Group Subset: Pregnant women_measurement 2
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| MEP | Diethyl phthalate (DEP) | NA | μg/L | 13 | 65.1 | 26.0 | 163 | -- | 31.5 | -- | -- | 100% | 8.0 |
| MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | NA | μg/L | 13 | 21.1 | 10.8 | 41.2 | -- | 23.2 | -- | -- | 100% | 2.0 |
Project: Maternal and Infant Environmental Exposure Project (MIEEP)
- Study Group: 92 pregnant women and their infants (65 mother-infant pairs and 27 pregnant women)
- Sample Collection Date: -
Chemical Group: Environmental Phenols
- Measured in: Urine
- Study Group Subset: Pregnant women
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| Benzophenone-3 | Benzophenone-3 | NA | μg/L | 89 | 33.0 | 20.5 | 53.2 | 8.41 | 26.6 | 124 | 1320 | 0.50 |
| BPA | Bisphenol A | NA | μg/L | 89 | 1.25 | 0.984 | 1.58 | 0.490 | 1.27 | 3.13 | 4.85 | 0.20 |
| Triclosan | Triclosan | NA | μg/L | 89 | 17.2 | 10.5 | 28.2 | 2.44 | 11.1 | 139 | 445 | 1.0 |
Chemical Group: Metals
- Measured in: Blood
- Study Group Subset: Pregnant women
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| Cadmium | Cadmium | NA | μg/L | 77 | 0.22 | 0.19 | 0.24 | 0.16 | 0.22 | 0.31 | 0.38 | 0.14 and 0.15** |
| Lead | Lead | NA | μg/dL | 77 | 0.65 | 0.57 | 0.75 | 0.45 | 0.60 | 0.84 | 1.6 | 0.027 |
| Mercury | Mercury | NA | μg/L | 77 | 0.45 | 0.37 | 0.54 | 0.26 | 0.46 | 0.76 | 1.1 | 0.064 |
Footnotes
- **LOD changed during the time that samples were analyzed for this project.
Chemical Group: Metals
- Measured in: Urine
- Study Group Subset: Pregnant women
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| Arsenic | Arsenic | NA | µg/L | 89 | 7.71 | 6.39 | 9.32 | 4.34 | 8.15 | 11.2 | 34.9 | 0.158 |
| Cadmium | Cadmium | Creatinine | μg/g creatinine | 89 | 0.185 | 0.160 | 0.213 | <LOD | 0.178 | 0.257 | 0.364 | 0.105 μg/L |
| Mercury | Mercury | NA | μg/L | 89 | 0.212 | 0.164 | 0.274 | 0.0897 | 0.176 | 0.429 | 0.997 | 0.0522 |
Chemical Group: Pesticidas Organoclorados
- Measured in: Serum
- Study Group Subset: Pregnant women
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| beta-Hexachlorocyclohexane (beta-HCH) | beta-HCH | Lipids | ng/g lipid | 77 | * | * | * | <LOD | 1.59 | 6.00 | 13.2 | 0.005 ng/mL |
| DDE (para,para) | para,para-DDT and/or para,para-DDE | Lipids | ng/g lipid | 77 | 112 | 85.1 | 149 | 53.0 | 94.0 | 161 | 516 | 0.005 ng/mL |
| DDT (ortho,para) | ortho,para-DDT | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.005 ng/mL |
| DDT (para,para) | para,para-DDT | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 18.2 | 0.005 ng/mL |
| Hexachlorobenzene (HCB) | HCB | Lipids | ng/g lipid | 77 | 8.26 | 7.58 | 8.99 | 6.50 | 8.43 | 10.1 | 12.5 | 0.034 ng/mL |
| Oxychlordane | Chlordane | Lipids | ng/g lipid | 77 | * | * | * | <LOD | 0.93 | 1.6 | 3.2 | 0.005 ng/mL |
| trans-Nonachlor | Chlordane | Lipids | ng/g lipid | 77 | 1.69 | 1.41 | 2.02 | 1.09 | 1.80 | 2.87 | 4.88 | 0.006 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Pesticidas Organofosfatos
- Measured in: Urine
- Study Group Subset: Pregnant women
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| DEDTP | Phorate and others | NA | μg/L | 89 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.10 |
| DEP | Chlorpyrifos, diazinon, and others | NA | μg/L | 89 | 1.41 | 1.10 | 1.80 | <LOD | 1.76 | 3.51 | 6.79 | 0.50 |
| DMDTP | Dimethoate, malathion, methidathion, phosmet, and others | NA | μg/L | 89 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0 |
| DMTP | Dimethoate, malathion, methidathion, phosmet, and others | NA | μg/L | 89 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.50 |
| TCPy | Chlorpyrifos | NA | μg/L | 89 | 0.52 | 0.41 | 0.65 | <LOD | 0.53 | 1.2 | 2.2 | 0.20 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
- Study Group Subset: Pregnant women
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 77 | * | * | * | <LOD | 0.012 | 0.021 | 0.026 | 0.011 |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 77 | 0.067 | 0.055 | 0.082 | 0.037 | 0.064 | 0.10 | 0.20 | 0.013 |
| PFBS | PFBS | NA | ng/mL | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.022 |
| PFDA | PFDA | NA | ng/mL | 77 | * | * | * | <LOD | <LOD | 0.035 | 0.64 | 0.032 |
| PFDoA | PFDoA | NA | ng/mL | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.036 |
| PFHpA | PFHpA | NA | ng/mL | 77 | * | * | * | <LOD | <LOD | 0.071 | 0.14 | 0.059 |
| PFNA | PFNA | NA | ng/mL | 77 | 0.733 | 0.621 | 0.865 | 0.504 | 0.791 | 1.11 | 1.74 | 0.075 |
| PFOA | PFOA | NA | ng/mL | 77 | * | * | * | <LOD | 0.474 | 0.811 | 1.25 | 0.30 |
| PFOS | PFOS | NA | ng/mL | 77 | 2.55 | 2.20 | 2.95 | 1.78 | 2.43 | 4.11 | 4.90 | 0.083 |
| PFOSA | PFOSA | NA | ng/mL | 77 | 0.019 | 0.016 | 0.022 | 0.012 | 0.017 | 0.026 | 0.049 | 0.01 |
| PFUnDA | PFUnDA | NA | ng/mL | 77 | 0.131 | 0.101 | 0.170 | 0.0730 | 0.165 | 0.261 | 0.474 | 0.01 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Ftalatos
- Measured in: Urine
- Study Group Subset: Pregnant women
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| MBzP | Benzylbutyl phthalate (BzBP) | NA | μg/L | 89 | 7.73 | 5.84 | 10.2 | 2.72 | 6.54 | 18.4 | 53.4 | 0.25 |
| MCHP | Dicyclohexyl phthalate (DCHP) | NA | μg/L | 89 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.50 |
| MCPP | Di-n-octyl phthalate (DnOP) | NA | μg/L | 89 | 0.87 | 0.72 | 1.05 | 0.48 | 0.75 | 1.2 | 2.8 | 0.125 |
| MECPP | Di-2-ethylhexyl phthalate (DEHP) | NA | μg/L | 89 | 17.1 | 13.5 | 21.7 | 8.09 | 14.6 | 29.4 | 68.8 | 0.50 |
| MEP | Diethyl phthalate (DEP) | NA | μg/L | 89 | 95.5 | 69.3 | 132 | 34.7 | 103 | 254 | 679 | 8.0 |
| MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | NA | μg/L | 89 | 16.3 | 13.0 | 20.5 | 6.59 | 16.2 | 34.2 | 60.8 | 2.0 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: éteres Difenílicos Polibromados (PBDEs)
- Measured in: Serum
- Study Group Subset: Pregnant women
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| BDE 017 | BDE 17 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.005 ng/mL |
| BDE 028 | BDE 28 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | 0.75 | 1.6 | 0.005 ng/mL |
| BDE 047 | BDE 47 | Lipids | ng/g lipid | 77 | 9.56 | 7.54 | 12.1 | 4.67 | 8.34 | 16.0 | 33.0 | 0.023 ng/mL |
| BDE 066 | BDE 66 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.005 ng/mL |
| BDE 085 | BDE 85 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.005 ng/mL |
| BDE 099 | BDE 99 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | 2.74 | 5.02 | 9.92 | 0.019 ng/mL |
| BDE 100 | BDE 100 | Lipids | ng/g lipid | 77 | 2.17 | 1.70 | 2.77 | 0.960 | 1.96 | 3.95 | 8.11 | 0.005 ng/mL |
| BDE 153 | BDE 153 | Lipids | ng/g lipid | 77 | 2.64 | 2.01 | 3.47 | 0.980 | 1.94 | 7.66 | 14.9 | 0.005 ng/mL |
| BDE 154 | BDE 154 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.007 ng/mL |
| BDE 183 | BDE 183 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.007 ng/mL |
| BDE 196 | BDE 196 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.007 ng/mL |
| BDE 197 | BDE 197 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | 0.93 | 1.5 | 0.007 ng/mL |
| BDE 201 | BDE 201 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.007 ng/mL |
| BDE 202 | BDE 202 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.007 ng/mL |
| BDE 203 | BDE 203 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.007 ng/mL |
| BDE 206 | BDE 206 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.009 ng/mL |
| BDE 207 | BDE 207 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 2.07 | 0.009 ng/mL |
| BDE 208 | BDE 208 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.009 ng/mL |
| BDE 209 | BDE 209 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | 5.41 | 9.31 | 13.5 | 0.045 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Bifenilos Policlorados (PCBs)
- Measured in: Serum
- Study Group Subset: Pregnant women
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| PCB 066 | PCB 66 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.009 ng/mL |
| PCB 074 | PCB 74 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 1.1 | 0.008 ng/mL |
| PCB 099 | PCB 99 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 2.23 | 0.014 ng/mL |
| PCB 101 | PCB 101 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 2.63 | 0.016 ng/mL |
| PCB 105 | PCB 105 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.010 ng/mL |
| PCB 118 | PCB 118 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | 2.02 | 2.97 | 0.014 ng/mL |
| PCB 138 | PCB 138 | Lipids | ng/g lipid | 77 | 1.94 | 1.69 | 2.22 | 1.29 | 1.90 | 2.63 | 4.15 | 0.006 ng/mL |
| PCB 153 | PCB 153 | Lipids | ng/g lipid | 77 | 2.98 | 2.57 | 3.46 | 1.95 | 3.02 | 4.29 | 6.59 | 0.011 ng/mL |
| PCB 156 | PCB 156 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 0.89 | 0.005 ng/mL |
| PCB 170 | PCB 170 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | 0.65 | 0.92 | 1.7 | 0.005 ng/mL |
| PCB 180 | PCB 180 | Lipids | ng/g lipid | 77 | 1.97 | 1.67 | 2.31 | 1.27 | 1.79 | 2.90 | 4.91 | 0.007 ng/mL |
| PCB 183 | PCB 183 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.012 ng/mL |
| PCB 187 | PCB 187 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | 1.2 | 1.7 | 0.009 ng/mL |
| PCB 194 | PCB 194 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 1.0 | 0.007 ng/mL |
| PCB 203 | PCB 203 | Lipids | ng/g lipid | 77 | * | * | * | <LOD | <LOD | 0.88 | 1.4 | 0.007 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Chemical Group: Hidrocarburos Aromáticos Policíclicos (PAHs)
- Measured in: Urine
- Study Group Subset: Pregnant women
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| 1-NAP | Naphthalene | NA | ng/L | 88 | 1020 | 800 | 1300 | 465 | 858 | 1940 | 4060 | 25.0 |
| 1-PHEN | Phenanthrene | NA | ng/L | 88 | 193 | 161 | 232 | 107 | 198 | 323 | 588 | 10.0 |
| 1-PYR | Pyrene | NA | ng/L | 88 | 186 | 153 | 227 | 88.2 | 211 | 334 | 598 | 20.0 |
| 2-FLUO | Fluorene | NA | ng/L | 88 | 192 | 157 | 235 | 96.0 | 188 | 311 | 529 | 20.0 |
| 2-NAP | Naphthalene | NA | ng/L | 88 | 6490 | 5140 | 8190 | 2780 | 6780 | 14000 | 23700 | 20.0 |
| 2-PHEN | Phenanthrene | NA | ng/L | 88 | 99.4 | 85.9 | 115 | 60.6 | 94.4 | 159 | 235 | 10.0 |
| 3-FLUO | Fluorene | NA | ng/L | 88 | 54.8 | 43.7 | 68.8 | 23.5 | 45.8 | 106 | 212 | 20.0 |
| 3-PHEN | Phenanthrene | NA | ng/L | 88 | 69.4 | 57.3 | 84.0 | 34.1 | 70.2 | 109 | 190 | 10.0 |
| 9-FLUO | Fluorene | NA | ng/L | 88 | 535 | 440 | 651 | 272 | 536 | 814 | 1370 | 37.0 |
Chemical Group: Pesticidas Piretroides
- Measured in: Urine
- Study Group Subset: Pregnant women
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| 3-Phenoxybenzoic acid (3-PBA) | Cyhalothrin, cypermethrin, deltamethrin, fenpropathrin, permethrin, and/or tralomethrin | NA | μg/L | 89 | * | * | * | <LOD | <LOD | 0.46 | 2.6 | 0.40 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 1
- Study Group: 460 pregnant individuals
- Sample Collection Date:
Chemical Group: Pesticidas Organoclorados
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.7% | 0.0107 ng/mL |
| DDE (para,para) | para,para-DDT and/or para,para-DDE | Lipids | ng/g lipid | 58 | 82.6 | 61.7 | 110 | 38.8 | 72.5 | 155 | 433 | 100% | 0.00837 ng/mL |
| DDT (ortho,para) | ortho,para-DDT | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.2% | 0.0100 ng/mL |
| DDT (para,para) | para,para-DDT | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | 1.85 | 5.59 | 25.9% | 0.0107 ng/mL |
| Hexachlorobenzene (HCB) | HCB | Lipids | ng/g lipid | 58 | 6.41 | 5.85 | 7.03 | 5.24 | 6.14 | 7.43 | 8.93 | 100% | 0.0116 ng/mL |
| Oxychlordane | Chlordane | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | 1.69 | 20.7% | 0.00618 ng/mL |
| trans-Nonachlor | Chlordane | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.7% | 0.0107 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: éteres Difenílicos Polibromados (PBDEs)
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| BDE 017 | BDE 17 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0107 ng/mL |
| BDE 028 | BDE 28 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.4% | 0.0107 ng/mL |
| BDE 047 | BDE 47 | Lipids | ng/g lipid | 58 | 13.7 | 11.1 | 16.8 | 6.57 | 13.9 | 22.8 | 38.7 | 75.9% | 0.0427 ng/mL |
| BDE 066 | BDE 66 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0107 ng/mL |
| BDE 085 | BDE 85 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0107 ng/mL |
| BDE 099 | BDE 99 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | 6.86 | 17.7 | 43.1% | 0.0233 ng/mL |
| BDE 100 | BDE 100 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | 2.57 | 5.04 | 12.4 | 62.1% | 0.0107 ng/mL |
| BDE 153 | BDE 153 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | 6.05 | 10.9 | 22.2 | 63.8% | 0.0233 ng/mL |
| BDE 154 | BDE 154 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0233 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Bifenilos Policlorados (PCBs)
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| PCB 066 | PCB 66 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.00850 ng/mL |
| PCB 074 | PCB 74 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | 0.992 | 15.5% | 0.00417 ng/mL |
| PCB 099 | PCB 99 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | 1.14 | 1.69 | 27.6% | 0.00733 ng/mL |
| PCB 101 | PCB 101 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0106 ng/mL |
| PCB 105 | PCB 105 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0107 ng/mL |
| PCB 118 | PCB 118 | Lipids | ng/g lipid | 58 | 1.42 | 1.25 | 1.62 | <LOD | 1.54 | 2.08 | 2.59 | 69.0% | 0.00705 ng/mL |
| PCB 138 | PCB 138 | Lipids | ng/g lipid | 58 | 2.34 | 1.99 | 2.74 | <LOD | 2.37 | 3.43 | 5.47 | 67.2% | 0.0107 ng/mL |
| PCB 153 | PCB 153 | Lipids | ng/g lipid | 58 | 3.16 | 2.59 | 3.85 | 2.05 | 3.01 | 5.20 | 8.05 | 91.4% | 0.00679 ng/mL |
| PCB 156 | PCB 156 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.4% | 0.0107 ng/mL |
| PCB 170 | PCB 170 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | 1.64 | 2.50 | 2.96 | 63.8% | 0.00696 ng/mL |
| PCB 180 | PCB 180 | Lipids | ng/g lipid | 58 | 2.94 | 2.44 | 3.54 | 2.00 | 2.98 | 4.93 | 7.09 | 82.8% | 0.00878 ng/mL |
| PCB 183 | PCB 183 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 6.9% | 0.0107 ng/mL |
| PCB 187 | PCB 187 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | 2.27 | 13.8% | 0.0107 ng/mL |
| PCB 194 | PCB 194 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 8.6% | 0.0107 ng/mL |
| PCB 203 | PCB 203 | Lipids | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | 1.55 | 10.3% | 0.0100 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
- Study Group Subset: Subsample 2
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 200 | * | * | * | <LOD | <LOD | 0.0185 | 0.0288 | 29.0% | 0.0164 ng/mL |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 200 | 0.0446 | 0.0379 | 0.0526 | 0.0177 | 0.0373 | 0.091 | 0.361 | 79.5% | 0.0147 ng/mL |
| PFDA | PFDA | NA | ng/mL | 200 | 0.198 | 0.174 | 0.226 | 0.0950 | 0.212 | 0.373 | 0.908 | 83.0% | 0.0652 ng/mL |
| PFDoA | PFDoA | NA | ng/mL | 200 | * | * | * | <LOD | <LOD | <LOD | 0.317 | 8.0% | 0.174 ng/mL |
| PFHpA | PFHpA | NA | ng/mL | 200 | 0.0453 | 0.0397 | 0.0515 | 0.0220 | 0.0484 | 0.0954 | 0.198 | 83.5% | 0.0149 ng/mL |
| PFHxS | PFHxS | NA | ng/mL | 200 | 0.904 | 0.818 | 0.998 | 0.558 | 0.861 | 1.43 | 2.83 | 100% | 0.0250 ng/mL |
| PFNA | PFNA | NA | ng/mL | 200 | 0.647 | 0.596 | 0.703 | 0.442 | 0.644 | 0.952 | 1.74 | 100% | 0.0302 ng/mL |
| PFOA | PFOA | NA | ng/mL | 200 | 1.243 | 1.154 | 1.339 | 0.898 | 1.29 | 1.77 | 2.81 | 100% | 0.0391 ng/mL |
| PFOS | PFOS | NA | ng/mL | 200 | 4.20 | 3.82 | 4.62 | 2.62 | 4.47 | 6.75 | 12.3 | 100% | 0.0565 ng/mL |
| PFOSA | PFOSA | NA | ng/mL | 200 | * | * | * | <LOD | <LOD | 0.00661 | 0.0266 | 33.5% | 0.00460 ng/mL |
| PFUnDA | PFUnDA | NA | ng/mL | 200 | 0.124 | 0.107 | 0.144 | 0.0483 | 0.118 | 0.275 | 0.717 | 78.0% | 0.0430 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 2
- Study Group: 540 pregnant individuals
- Sample Collection Date: -
Chemical Group: Pesticidas Organoclorados
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | ng/g lipid | 242 | * | * | * | <LOD | 3.05 | 4.39 | 7.84 | 64.5% | 0.0160 and 0.0180 ng/mL** |
| DDE (para,para) | para,para-DDT and/or para,para-DDE | ng/g lipid | 242 | 47.6 | 42.6 | 53.3 | 29.0 | 41.4 | 65.8 | 221 | 100% | 0.0181 and 0.0359 ng/mL** |
| DDT (ortho,para) | ortho,para-DDT | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0160 and 0.0180 ng/mL** |
| DDT (para,para) | para,para-DDT | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 2.98 | 9.1% | 0.0160 and 0.0180 ng/mL** |
| Hexachlorobenzene (HCB) | HCB | ng/g lipid | 242 | 11.4 | 10.8 | 11.9 | 8.98 | 11.2 | 13.5 | 21.7 | 93.4% | 0.0399 and 0.0875 ng/mL** |
| Oxychlordane | Chlordane | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.5% | 0.0160 and 0.0180 ng/mL** |
| trans-Nonachlor | Chlordane | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 2.18 | 24.4% | 0.0160 and 0.0180 ng/mL** |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- **LOD changed during the time that samples were analyzed for this project.
Chemical Group: éteres Difenílicos Polibromados (PBDEs)
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| BDE 017 | BDE 17 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.0160 ng/mL |
| BDE 028 | BDE 28 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.9% | 0.0160 ng/mL |
| BDE 047 | BDE 47 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | 13.6 | 33.4 | 46.5% | 0.0640 ng/mL |
| BDE 066 | BDE 66 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0160 ng/mL |
| BDE 085 | BDE 85 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.6% | 0.0160 ng/mL |
| BDE 099 | BDE 99 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | 4.97 | 11.5 | 26.9% | 0.0350 ng/mL |
| BDE 100 | BDE 100 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | 3.59 | 8.99 | 46.5% | 0.0160 ng/mL |
| BDE 153 | BDE 153 | ng/g lipid | 245 | * | * | * | <LOD | 6.68 | 11.3 | 25.2 | 58.4% | 0.0320 ng/mL |
| BDE 154 | BDE 154 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.0320 ng/mL |
| BDE 183 | BDE 183 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0320 ng/mL |
| BDE 196 | BDE 196 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.6% | 0.0320 ng/mL |
| BDE 197 | BDE 197 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.3% | 0.0320 ng/mL |
| BDE 201 | BDE 201 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0320 ng/mL |
| BDE 202 | BDE 202 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0320 ng/mL |
| BDE 203 | BDE 203 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.6% | 0.0320 ng/mL |
| BDE 206 | BDE 206 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0400 ng/mL |
| BDE 207 | BDE 207 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.9% | 0.0400 ng/mL |
| BDE 208 | BDE 208 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.6% | 0.0400 ng/mL |
| BDE 209 | BDE 209 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.300 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Bifenilos Policlorados (PCBs)
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| PCB 066 | PCB 66 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0160 and 0.0180 ng/mL** |
| PCB 074 | PCB 74 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.7% | 0.0160 and 0.0180 ng/mL** |
| PCB 099 | PCB 99 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.3% | 0.0160 and 0.0180 ng/mL** |
| PCB 101 | PCB 101 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.8% | 0.0160 and 0.0180 ng/mL** |
| PCB 105 | PCB 105 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.8% | 0.0160 and 0.0180 ng/mL** |
| PCB 118 | PCB 118 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 3.03 | 16.9% | 0.0160 and 0.0180 ng/mL** |
| PCB 138 | PCB 138 | ng/g lipid | 242 | * | * | * | <LOD | 2.50 | 3.45 | 5.80 | 56.2% | 0.0160 and 0.0180 ng/mL** |
| PCB 153 | PCB 153 | ng/g lipid | 242 | 3.16 | 2.93 | 3.41 | <LOD | 2.89 | 4.41 | 8.25 | 65.3% | 0.0160 and 0.0180 ng/mL** |
| PCB 156 | PCB 156 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0160 and 0.0180 ng/mL** |
| PCB 170 | PCB 170 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 3.64 | 18.2% | 0.0160 and 0.0180 ng/mL** |
| PCB 180 | PCB 180 | ng/g lipid | 242 | * | * | * | <LOD | 2.66 | 4.04 | 8.43 | 59.9% | 0.0160 and 0.0180 ng/mL** |
| PCB 183 | PCB 183 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0160 and 0.0180 ng/mL** |
| PCB 187 | PCB 187 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 3.29 | 11.6% | 0.0160 and 0.0180 ng/mL** |
| PCB 194 | PCB 194 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.0% | 0.0160 and 0.0180 ng/mL** |
| PCB 203 | PCB 203 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | 2.69 | 4.35 | 26.9% | 0.0173 and 0.0188 ng/mL** |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- **LOD changed during the time that samples were analyzed for this project.
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
- Study Group Subset: Subsample 2
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| 4:2 FTS | 4:2 FTS | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0463 | 6.2% | 0.0372 ng/mL |
| 5:3 FTCA | 5:3 FTCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.7% | 0.0500 ng/mL |
| 6:2 diPAP | 6:2 diPAP | ng/mL | 277 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.5% | 0.0645 ng/mL |
| 6:2 FTCA | 6:2 FTCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
| 6:2 FTS | 6:2 FTS | ng/mL | 240 | * | * | * | <LOD | <LOD | <LOD | 0.781 | 20.8% | 0.188 ng/mL |
| 6:2 FTUCA | 6:2 FTUCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0243 ng/mL |
| 6:6 PFPiA | 6:6 PFPiA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0429 ng/mL |
| 7:3 FTCA | 7:3 FTCA | ng/mL | 291 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.8% | 0.0622 ng/mL |
| 8:2 diPAP | 8:2 diPAP | ng/mL | 291 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/ml |
| 8:2 FTCA | 8:2 FTCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
| 8:2 FTS | 8:2 FTS | ng/mL | 290 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.4% | 0.0500 ng/mL |
| 8:2 FTUCA | 8:2 FTUCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0280 ng/mL |
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 292 | * | * | * | <LOD | <LOD | 0.0179 | 0.0398 | 35.6% | 0.0131 ng/mL |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 292 | * | * | * | <LOD | <LOD | 0.107 | 0.287 | 45.5% | 0.0638 ng/mL |
| PFBA | PFBA | ng/mL | 292 | 0.0577 | 0.0550 | 0.0606 | <LOD | 0.0594 | 0.0770 | 0.121 | 65.8% | 0.0500 ng/mL |
| PFBS | PFBS | ng/mL | 292 | * | * | * | <LOD | <LOD | 0.0119 | 0.0283 | 25.0% | 0.0140 ng/mL |
| PFDA | PFDA | ng/mL | 292 | 0.213 | 0.196 | 0.231 | 0.135 | 0.189 | 0.320 | 0.752 | 99.0% | 0.0542 ng/mL |
| PFDoA | PFDoA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0854 | 16.4% | 0.0500 ng/mL |
| PFDS | PFDS | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0308 | 5.8% | 0.0274 ng/mL |
| PFHpA | PFHpA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.103 | 24.0% | 0.0500 ng/ml |
| PFHxA | PFHxA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0925 | 5.5% | 0.0818 ng/mL |
| PFHxPA | PFHxPA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 ng/mL |
| PFHxS | PFHxS | ng/mL | 292 | 0.743 | 0.690 | 0.800 | 0.496 | 0.720 | 1.00 | 2.66 | 100% | 0.0195 ng/ml |
| PFNA | PFNA | ng/mL | 292 | 0.542 | 0.509 | 0.578 | 0.372 | 0.527 | 0.774 | 1.39 | 100% | 0.0487 ng/mL |
| PFOA | PFOA | ng/mL | 292 | 1.01 | 0.942 | 1.09 | 0.631 | 1.02 | 1.55 | 2.88 | 100% | 0.0539 ng/mL |
| PFOS | PFOS | ng/mL | 292 | 3.10 | 2.88 | 3.33 | 2.05 | 3.09 | 4.41 | 9.07 | 100% | 0.316 ng/mL |
| PFOSA | PFOSA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.4% | 0.0173 ng/mL |
| PFPeA | PFPeA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0255 | 6.5% | 0.0235 ng/mL |
| PFUnDA | PFUnDA | ng/mL | 292 | 0.129 | 0.115 | 0.145 | 0.0646 | 0.118 | 0.275 | 0.726 | 81.2% | 0.0481 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 3
- Study Group: 300 pregnant individuals
- Sample Collection Date: -
Chemical Group: Pesticidas Organoclorados
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 4.12 | 17.6% | 0.0160 ng/mL |
| DDE (para,para) | para,para-DDT and/or para,para-DDE | ng/g lipid | 204 | 11.1 | 9.59 | 12.9 | 4.71 | 9.50 | 18.4 | 97.1 | 75.5% | 0.0320 ng/mL |
| DDT (ortho,para) | ortho,para-DDT | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| DDT (para,para) | para,para-DDT | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.4% | 0.0160 ng/mL |
| Hexachlorobenzene (HCB) | HCB | ng/g lipid | 204 | 10.3 | 10.0 | 10.6 | 8.99 | 10.2 | 11.7 | 14.0 | 100% | 0.0230 ng/mL |
| Oxychlordane | Chlordane | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| trans-Nonachlor | Chlordane | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.5% | 0.0160 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: éteres Difenílicos Polibromados (PBDEs)
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| BDE 017 | BDE 17 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| BDE 028 | BDE 28 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| BDE 047 | BDE 47 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | 4.05 | 8.30 | 34.8% | 0.0240 ng/mL |
| BDE 066 | BDE 66 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| BDE 085 | BDE 85 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| BDE 099 | BDE 99 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 4.80 | 11.7% | 0.0220 ng/mL |
| BDE 100 | BDE 100 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 2.66 | 5.4% | 0.0160 ng/mL |
| BDE 153 | BDE 153 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 13.8 | 24.5% | 0.0320 ng/mL |
| BDE 154 | BDE 154 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
| BDE 183 | BDE 183 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
| BDE 196 | BDE 196 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
| BDE 197 | BDE 197 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.5% | 0.0320 ng/mL |
| BDE 201 | BDE 201 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
| BDE 202 | BDE 202 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
| BDE 203 | BDE 203 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
| BDE 206 | BDE 206 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.5% | 0.0400 ng/mL |
| BDE 207 | BDE 207 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.0400 ng/mL |
| BDE 208 | BDE 208 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.5% | 0.0400 ng/mL |
| BDE 209 | BDE 209 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.5% | 0.300 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Bifenilos Policlorados (PCBs)
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| PCB 066 | PCB 66 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| PCB 074 | PCB 74 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.0160 ng/mL |
| PCB 099 | PCB 99 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.0160 ng/mL |
| PCB 101 | PCB 101 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| PCB 105 | PCB 105 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| PCB 118 | PCB 118 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.0160 ng/mL |
| PCB 138 | PCB 138 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 2.80 | 8.3% | 0.0160 ng/mL |
| PCB 153 | PCB 153 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | 2.44 | 4.40 | 27.0% | 0.0160 ng/mL |
| PCB 156 | PCB 156 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.0160 ng/mL |
| PCB 170 | PCB 170 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 2.66 | 5.4% | 0.0160 ng/mL |
| PCB 180 | PCB 180 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | 3.44 | 6.90 | 44.6% | 0.0160 ng/mL |
| PCB 183 | PCB 183 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| PCB 187 | PCB 187 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.4% | 0.0160 ng/mL |
| PCB 194 | PCB 194 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.4% | 0.0160 ng/mL |
| PCB 203 | PCB 203 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 3.08 | 18.6% | 0.0160 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
- Study Group Subset: Subsample 2
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| 4:2 FTS | 4:2 FTS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0372 ng/mL |
| 5:3 FTCA | 5:3 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 7.3% | 0.0500 ng/mL |
| 6:2 diPAP | 6:2 diPAP | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0645 ng/mL |
| 6:2 FTCA | 6:2 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.2% | 0.250 ng/mL |
| 6:2 FTS | 6:2 FTS | ng/mL | 87 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.188 ng/mL |
| 6:2 FTUCA | 6:2 FTUCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0243 ng/mL |
| 6:6 PFPiA | 6:6 PFPiA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0429 ng/mL |
| 6:8 PFPiA | 6:8 PFPiA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.198 ng/mL |
| 7:3 FTCA | 7:3 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0622 ng/mL |
| 8:2 diPAP | 8:2 diPAP | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
| 8:2 FTCA | 8:2 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
| 8:2 FTS | 8:2 FTS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0500 ng/mL |
| 8:2 FTUCA | 8:2 FTUCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0280 ng/mL |
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | 0.0136 | 11.5% | 0.0131 ng/mL |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 22.9% | 0.0638 ng/mL |
| PFBA | PFBA | ng/mL | 96 | 0.0760 | 0.0697 | 0.0828 | 0.0645 | 0.0845 | 0.0990 | 0.117 | 82.3% | 0.0500 ng/mL |
| PFBS | PFBS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 7.3% | 0.0140 ng/mL |
| PFDA | PFDA | ng/mL | 96 | 0.187 | 0.160 | 0.220 | 0.109 | 0.169 | 0.285 | 0.613 | 99.0% | 0.0542 ng/mL |
| PFDoA | PFDoA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | 0.0741 | 17.7% | 0.0500 ng/mL |
| PFDS | PFDS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 6.3% | 0.0274 ng/mL |
| PFHpA | PFHpA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0107 ng/mL |
| PFHxA | PFHxA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.108 ng/mL |
| PFHxPA | PFHxPA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 ng/mL |
| PFHxS | PFHxS | ng/mL | 96 | 0.416 | 0.366 | 0.473 | 0.272 | 0.386 | 0.606 | 0.951 | 100% | 0.0472 ng/mL |
| PFNA | PFNA | ng/mL | 96 | 0.406 | 0.360 | 0.457 | 0.263 | 0.426 | 0.564 | 0.830 | 100% | 0.0767 ng/mL |
| PFOA | PFOA | ng/mL | 96 | 0.892 | 0.783 | 1.02 | 0.604 | 0.895 | 1.29 | 2.00 | 100% | 0.0539 ng/mL |
| PFOPA | PFOPA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 ng/mL |
| PFOS | PFOS | ng/mL | 96 | 2.39 | 2.08 | 2.75 | 1.47 | 2.47 | 3.56 | 5.42 | 100% | 0.316 ng/mL |
| PFOSA | PFOSA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0173 ng/mL |
| PFPeA | PFPeA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.2% | 0.0235 ng/mL |
| PFUnDA | PFUnDA | ng/mL | 96 | 0.121 | 0.0990 | 0.147 | 0.0584 | 0.108 | 0.215 | 0.532 | 79.2% | 0.0481 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
This page is tagged as Spanish. View English site.